<?xml version="1.0" encoding="us-ascii" standalone="yes"?>
<!--XBRL Document Created with XBRLMaster-->
<!--Version: 2.3.08-->
<!--Based on XBRL 2.1-->
<!--Date of creation: 08/03/2026-->
<!--Software architectural design and coding: A'c Dharmapremananda Avt.-->
<!--Copyright (c) 2026 I-NET Business Solutions, Inc. All Rights Reserved.-->
<link:linkbase xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:link="http://www.xbrl.org/2003/linkbase" xsi:schemaLocation="http://www.xbrl.org/2003/linkbase http://www.xbrl.org/2003/xbrl-linkbase-2003-12-31.xsd">
  <link:roleRef roleURI="http://pharmaceuticalresource.com/role/Cover" xlink:href="prt-20260630.xsd#Cover" xlink:type="simple" />
  <link:roleRef roleURI="http://pharmaceuticalresource.com/role/CondensedConsolidatedBalanceSheet" xlink:href="prt-20260630.xsd#CondensedConsolidatedBalanceSheet" xlink:type="simple" />
  <link:roleRef roleURI="http://pharmaceuticalresource.com/role/CondensedConsolidatedBalanceSheetParenthetical" xlink:href="prt-20260630.xsd#CondensedConsolidatedBalanceSheetParenthetical" xlink:type="simple" />
  <link:roleRef roleURI="http://pharmaceuticalresource.com/role/CondensedConsolidatedStatementOfOperationsUnaudited" xlink:href="prt-20260630.xsd#CondensedConsolidatedStatementOfOperationsUnaudited" xlink:type="simple" />
  <link:roleRef roleURI="http://pharmaceuticalresource.com/role/CondensedConsolidatedCashFlowStatementUnaudited" xlink:href="prt-20260630.xsd#CondensedConsolidatedCashFlowStatementUnaudited" xlink:type="simple" />
  <link:roleRef roleURI="http://pharmaceuticalresource.com/role/CondensedStockholdersEquityUnaudited" xlink:href="prt-20260630.xsd#CondensedStockholdersEquityUnaudited" xlink:type="simple" />
  <link:roleRef roleURI="http://xbrl.sec.gov/ecd/role/InsiderTradingArrangements" xlink:href="https://xbrl.sec.gov/ecd/2025/ecd-2025.xsd#InsiderTradingArrangements" xlink:type="simple" />
  <link:roleRef roleURI="http://pharmaceuticalresource.com/role/OverviewAndBasisOfPresentation" xlink:href="prt-20260630.xsd#OverviewAndBasisOfPresentation" xlink:type="simple" />
  <link:roleRef roleURI="http://pharmaceuticalresource.com/role/GoingConcern" xlink:href="prt-20260630.xsd#GoingConcern" xlink:type="simple" />
  <link:roleRef roleURI="http://pharmaceuticalresource.com/role/SummaryOfSignificantPolicies" xlink:href="prt-20260630.xsd#SummaryOfSignificantPolicies" xlink:type="simple" />
  <link:roleRef roleURI="http://pharmaceuticalresource.com/role/CommonStocks" xlink:href="prt-20260630.xsd#CommonStocks" xlink:type="simple" />
  <link:roleRef roleURI="http://pharmaceuticalresource.com/role/SegmentReporting" xlink:href="prt-20260630.xsd#SegmentReporting" xlink:type="simple" />
  <link:roleRef roleURI="http://pharmaceuticalresource.com/role/IncomeTaxes" xlink:href="prt-20260630.xsd#IncomeTaxes" xlink:type="simple" />
  <link:roleRef roleURI="http://pharmaceuticalresource.com/role/ConcentrationOfCreditRiskAndSignificantCustomers" xlink:href="prt-20260630.xsd#ConcentrationOfCreditRiskAndSignificantCustomers" xlink:type="simple" />
  <link:roleRef roleURI="http://pharmaceuticalresource.com/role/SubsequentEvents" xlink:href="prt-20260630.xsd#SubsequentEvents" xlink:type="simple" />
  <link:roleRef roleURI="http://pharmaceuticalresource.com/role/ShareholderEquity" xlink:href="prt-20260630.xsd#ShareholderEquity" xlink:type="simple" />
  <link:roleRef roleURI="http://pharmaceuticalresource.com/role/SummaryOfSignificantPoliciesPolicies" xlink:href="prt-20260630.xsd#SummaryOfSignificantPoliciesPolicies" xlink:type="simple" />
  <link:roleRef roleURI="http://pharmaceuticalresource.com/role/SummaryOfSignificantPoliciesTables" xlink:href="prt-20260630.xsd#SummaryOfSignificantPoliciesTables" xlink:type="simple" />
  <link:roleRef roleURI="http://pharmaceuticalresource.com/role/SegmentReportingTables" xlink:href="prt-20260630.xsd#SegmentReportingTables" xlink:type="simple" />
  <link:roleRef roleURI="http://pharmaceuticalresource.com/role/GoingConcernDetailsNarrative" xlink:href="prt-20260630.xsd#GoingConcernDetailsNarrative" xlink:type="simple" />
  <link:roleRef roleURI="http://pharmaceuticalresource.com/role/SummaryOfSignificantPoliciesDetails" xlink:href="prt-20260630.xsd#SummaryOfSignificantPoliciesDetails" xlink:type="simple" />
  <link:roleRef roleURI="http://pharmaceuticalresource.com/role/SummaryOfSignificantPoliciesDetails1" xlink:href="prt-20260630.xsd#SummaryOfSignificantPoliciesDetails1" xlink:type="simple" />
  <link:roleRef roleURI="http://pharmaceuticalresource.com/role/SummaryOfSignificantPoliciesDetails2" xlink:href="prt-20260630.xsd#SummaryOfSignificantPoliciesDetails2" xlink:type="simple" />
  <link:roleRef roleURI="http://pharmaceuticalresource.com/role/SummaryOfSignificantPoliciesDetails3" xlink:href="prt-20260630.xsd#SummaryOfSignificantPoliciesDetails3" xlink:type="simple" />
  <link:roleRef roleURI="http://pharmaceuticalresource.com/role/SummaryOfSignificantPoliciesDetails4" xlink:href="prt-20260630.xsd#SummaryOfSignificantPoliciesDetails4" xlink:type="simple" />
  <link:roleRef roleURI="http://pharmaceuticalresource.com/role/SummaryOfSignificantPoliciesDetails5" xlink:href="prt-20260630.xsd#SummaryOfSignificantPoliciesDetails5" xlink:type="simple" />
  <link:roleRef roleURI="http://pharmaceuticalresource.com/role/SummaryOfSignificantPoliciesDetails6" xlink:href="prt-20260630.xsd#SummaryOfSignificantPoliciesDetails6" xlink:type="simple" />
  <link:roleRef roleURI="http://pharmaceuticalresource.com/role/SummaryOfSignificantPoliciesDetails7" xlink:href="prt-20260630.xsd#SummaryOfSignificantPoliciesDetails7" xlink:type="simple" />
  <link:roleRef roleURI="http://pharmaceuticalresource.com/role/SummaryOfSignificantPoliciesDetails8" xlink:href="prt-20260630.xsd#SummaryOfSignificantPoliciesDetails8" xlink:type="simple" />
  <link:roleRef roleURI="http://pharmaceuticalresource.com/role/SummaryOfSignificantPoliciesDetails9" xlink:href="prt-20260630.xsd#SummaryOfSignificantPoliciesDetails9" xlink:type="simple" />
  <link:roleRef roleURI="http://pharmaceuticalresource.com/role/SummaryOfSignificantPoliciesDetails10" xlink:href="prt-20260630.xsd#SummaryOfSignificantPoliciesDetails10" xlink:type="simple" />
  <link:roleRef roleURI="http://pharmaceuticalresource.com/role/SummaryOfSignificantPoliciesDetailsNarrative" xlink:href="prt-20260630.xsd#SummaryOfSignificantPoliciesDetailsNarrative" xlink:type="simple" />
  <link:roleRef roleURI="http://pharmaceuticalresource.com/role/CommonStocksDetailsNarrative" xlink:href="prt-20260630.xsd#CommonStocksDetailsNarrative" xlink:type="simple" />
  <link:roleRef roleURI="http://pharmaceuticalresource.com/role/SegmentReportingDetails" xlink:href="prt-20260630.xsd#SegmentReportingDetails" xlink:type="simple" />
  <link:roleRef roleURI="http://pharmaceuticalresource.com/role/SegmentReportingDetails1" xlink:href="prt-20260630.xsd#SegmentReportingDetails1" xlink:type="simple" />
  <link:roleRef roleURI="http://pharmaceuticalresource.com/role/SegmentReportingDetails2" xlink:href="prt-20260630.xsd#SegmentReportingDetails2" xlink:type="simple" />
  <link:roleRef roleURI="http://pharmaceuticalresource.com/role/IncomeTaxesDetailsNarrative" xlink:href="prt-20260630.xsd#IncomeTaxesDetailsNarrative" xlink:type="simple" />
  <link:roleRef roleURI="http://pharmaceuticalresource.com/role/ConcentrationOfCreditRiskAndSignificantCustomersDetailsNarrative" xlink:href="prt-20260630.xsd#ConcentrationOfCreditRiskAndSignificantCustomersDetailsNarrative" xlink:type="simple" />
  <link:roleRef roleURI="http://pharmaceuticalresource.com/role/ShareholderEquityDetailsNarrative" xlink:href="prt-20260630.xsd#ShareholderEquityDetailsNarrative" xlink:type="simple" />
  <link:presentationLink xlink:type="extended" xlink:role="http://pharmaceuticalresource.com/role/Cover" xlink:title="00000001 - Document - Cover Page Information">
    <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_CoverAbstract" xlink:label="loc_deiCoverAbstract" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_EntityRegistrantName" xlink:label="loc_deiEntityRegistrantName" />
    <link:presentationArc order="0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiEntityRegistrantName" xlink:type="arc" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_EntityCentralIndexKey" xlink:label="loc_deiEntityCentralIndexKey" />
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiEntityCentralIndexKey" xlink:type="arc" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_DocumentType" xlink:label="loc_deiDocumentType" />
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiDocumentType" xlink:type="arc" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_AmendmentFlag" xlink:label="loc_deiAmendmentFlag" />
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiAmendmentFlag" xlink:type="arc" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_CurrentFiscalYearEndDate" xlink:label="loc_deiCurrentFiscalYearEndDate" />
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiCurrentFiscalYearEndDate" xlink:type="arc" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_EntitySmallBusiness" xlink:label="loc_deiEntitySmallBusiness" />
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiEntitySmallBusiness" xlink:type="arc" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_EntityShellCompany" xlink:label="loc_deiEntityShellCompany" />
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiEntityShellCompany" xlink:type="arc" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_EntityEmergingGrowthCompany" xlink:label="loc_deiEntityEmergingGrowthCompany" />
    <link:presentationArc order="7" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiEntityEmergingGrowthCompany" xlink:type="arc" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_EntityCurrentReportingStatus" xlink:label="loc_deiEntityCurrentReportingStatus" />
    <link:presentationArc order="8" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiEntityCurrentReportingStatus" xlink:type="arc" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_DocumentPeriodEndDate" xlink:label="loc_deiDocumentPeriodEndDate" />
    <link:presentationArc order="9" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiDocumentPeriodEndDate" xlink:type="arc" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_EntityFilerCategory" xlink:label="loc_deiEntityFilerCategory" />
    <link:presentationArc order="10" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiEntityFilerCategory" xlink:type="arc" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_DocumentFiscalPeriodFocus" xlink:label="loc_deiDocumentFiscalPeriodFocus" />
    <link:presentationArc order="11" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiDocumentFiscalPeriodFocus" xlink:type="arc" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_DocumentFiscalYearFocus" xlink:label="loc_deiDocumentFiscalYearFocus" />
    <link:presentationArc order="12" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiDocumentFiscalYearFocus" xlink:type="arc" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_EntityExTransitionPeriod" xlink:label="loc_deiEntityExTransitionPeriod" />
    <link:presentationArc order="13" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiEntityExTransitionPeriod" xlink:type="arc" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_EntityCommonStockSharesOutstanding" xlink:label="loc_deiEntityCommonStockSharesOutstanding" />
    <link:presentationArc order="14" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiEntityCommonStockSharesOutstanding" xlink:type="arc" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_DocumentQuarterlyReport" xlink:label="loc_deiDocumentQuarterlyReport" />
    <link:presentationArc order="15" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiDocumentQuarterlyReport" xlink:type="arc" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_DocumentTransitionReport" xlink:label="loc_deiDocumentTransitionReport" />
    <link:presentationArc order="16" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiDocumentTransitionReport" xlink:type="arc" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_EntityFileNumber" xlink:label="loc_deiEntityFileNumber" />
    <link:presentationArc order="17" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiEntityFileNumber" xlink:type="arc" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_EntityIncorporationStateCountryCode" xlink:label="loc_deiEntityIncorporationStateCountryCode" />
    <link:presentationArc order="18" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiEntityIncorporationStateCountryCode" xlink:type="arc" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_EntityAddressAddressLine1" xlink:label="loc_deiEntityAddressAddressLine1" />
    <link:presentationArc order="19" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiEntityAddressAddressLine1" xlink:type="arc" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_EntityAddressAddressLine2" xlink:label="loc_deiEntityAddressAddressLine2" />
    <link:presentationArc order="20" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiEntityAddressAddressLine2" xlink:type="arc" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_EntityAddressAddressLine3" xlink:label="loc_deiEntityAddressAddressLine3" />
    <link:presentationArc order="21" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiEntityAddressAddressLine3" xlink:type="arc" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_EntityAddressCountry" xlink:label="loc_deiEntityAddressCountry" />
    <link:presentationArc order="22" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiEntityAddressCountry" xlink:type="arc" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_EntityAddressPostalZipCode" xlink:label="loc_deiEntityAddressPostalZipCode" />
    <link:presentationArc order="23" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiEntityAddressPostalZipCode" xlink:type="arc" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_CityAreaCode" xlink:label="loc_deiCityAreaCode" />
    <link:presentationArc order="24" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiCityAreaCode" xlink:type="arc" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_LocalPhoneNumber" xlink:label="loc_deiLocalPhoneNumber" />
    <link:presentationArc order="25" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiLocalPhoneNumber" xlink:type="arc" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_Security12bTitle" xlink:label="loc_deiSecurity12bTitle" />
    <link:presentationArc order="26" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiSecurity12bTitle" xlink:type="arc" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_EntityInteractiveDataCurrent" xlink:label="loc_deiEntityInteractiveDataCurrent" />
    <link:presentationArc order="27" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiEntityInteractiveDataCurrent" xlink:type="arc" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_EntityTaxIdentificationNumber" xlink:label="loc_deiEntityTaxIdentificationNumber" />
    <link:presentationArc order="28" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiEntityTaxIdentificationNumber" xlink:type="arc" />
  </link:presentationLink>
  <link:presentationLink xlink:type="extended" xlink:role="http://pharmaceuticalresource.com/role/CondensedConsolidatedBalanceSheet" xlink:title="110200 - Statement - Condensed Consolidated Balance Sheet">
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_StatementOfFinancialPositionAbstract" xlink:label="loc_us-gaapStatementOfFinancialPositionAbstract_10a1ef" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_AssetsAbstract" xlink:label="loc_us-gaapAssetsAbstract_c7e825" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementOfFinancialPositionAbstract_10a1ef" xlink:to="loc_us-gaapAssetsAbstract_c7e825" order="1" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_AssetsCurrentAbstract" xlink:label="loc_us-gaapAssetsCurrentAbstract_356865" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementOfFinancialPositionAbstract_10a1ef" xlink:to="loc_us-gaapAssetsCurrentAbstract_356865" order="2" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents" xlink:label="loc_us-gaapCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents_2f2b02" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementOfFinancialPositionAbstract_10a1ef" xlink:to="loc_us-gaapCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents_2f2b02" order="3" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_AccountsReceivableNetCurrent" xlink:label="loc_us-gaapAccountsReceivableNetCurrent_237396" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementOfFinancialPositionAbstract_10a1ef" xlink:to="loc_us-gaapAccountsReceivableNetCurrent_237396" order="4" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_InventoryNet" xlink:label="loc_us-gaapInventoryNet_b0d18d" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementOfFinancialPositionAbstract_10a1ef" xlink:to="loc_us-gaapInventoryNet_b0d18d" order="5" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_AssetsCurrent" xlink:label="loc_us-gaapAssetsCurrent_19881d" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementOfFinancialPositionAbstract_10a1ef" xlink:to="loc_us-gaapAssetsCurrent_19881d" order="6" preferredLabel="http://www.xbrl.org/2003/role/totalLabel" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_PropertyPlantAndEquipmentNet" xlink:label="loc_us-gaapPropertyPlantAndEquipmentNet_56123d" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementOfFinancialPositionAbstract_10a1ef" xlink:to="loc_us-gaapPropertyPlantAndEquipmentNet_56123d" order="7" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_OperatingLeaseRightOfUseAsset" xlink:label="loc_us-gaapOperatingLeaseRightOfUseAsset_53465d" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementOfFinancialPositionAbstract_10a1ef" xlink:to="loc_us-gaapOperatingLeaseRightOfUseAsset_53465d" order="8" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_FiniteLivedIntangibleAssetsNet" xlink:label="loc_us-gaapFiniteLivedIntangibleAssetsNet_95b700" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementOfFinancialPositionAbstract_10a1ef" xlink:to="loc_us-gaapFiniteLivedIntangibleAssetsNet_95b700" order="9" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_Assets" xlink:label="loc_us-gaapAssets_840595" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementOfFinancialPositionAbstract_10a1ef" xlink:to="loc_us-gaapAssets_840595" order="10" preferredLabel="http://www.xbrl.org/2003/role/totalLabel" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_LiabilitiesAbstract" xlink:label="loc_us-gaapLiabilitiesAbstract_6a51df" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementOfFinancialPositionAbstract_10a1ef" xlink:to="loc_us-gaapLiabilitiesAbstract_6a51df" order="11" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_LiabilitiesCurrentAbstract" xlink:label="loc_us-gaapLiabilitiesCurrentAbstract_06fe28" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementOfFinancialPositionAbstract_10a1ef" xlink:to="loc_us-gaapLiabilitiesCurrentAbstract_06fe28" order="12" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_AccountsPayableAndAccruedLiabilitiesCurrent" xlink:label="loc_us-gaapAccountsPayableAndAccruedLiabilitiesCurrent_ecf0cc" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapLiabilitiesCurrentAbstract_06fe28" xlink:to="loc_us-gaapAccountsPayableAndAccruedLiabilitiesCurrent_ecf0cc" order="13" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_OperatingLeaseLiabilityCurrent" xlink:label="loc_us-gaapOperatingLeaseLiabilityCurrent_f8edab" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementOfFinancialPositionAbstract_10a1ef" xlink:to="loc_us-gaapOperatingLeaseLiabilityCurrent_f8edab" order="14" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_LiabilitiesCurrent" xlink:label="loc_us-gaapLiabilitiesCurrent_97a1d7" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementOfFinancialPositionAbstract_10a1ef" xlink:to="loc_us-gaapLiabilitiesCurrent_97a1d7" order="15" preferredLabel="http://www.xbrl.org/2003/role/totalLabel" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_OperatingLeaseLiabilityNoncurrent" xlink:label="loc_us-gaapOperatingLeaseLiabilityNoncurrent_5d3a67" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementOfFinancialPositionAbstract_10a1ef" xlink:to="loc_us-gaapOperatingLeaseLiabilityNoncurrent_5d3a67" order="16" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_Liabilities" xlink:label="loc_us-gaapLiabilities_cb8e6e" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementOfFinancialPositionAbstract_10a1ef" xlink:to="loc_us-gaapLiabilities_cb8e6e" order="17" preferredLabel="http://www.xbrl.org/2003/role/totalLabel" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_StockholdersEquityAbstract" xlink:label="loc_us-gaapStockholdersEquityAbstract_eae148" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementOfFinancialPositionAbstract_10a1ef" xlink:to="loc_us-gaapStockholdersEquityAbstract_eae148" order="18" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_CommonStockValue" xlink:label="loc_us-gaapCommonStockValue_e99831" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStockholdersEquityAbstract_eae148" xlink:to="loc_us-gaapCommonStockValue_e99831" order="19" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_AdditionalPaidInCapital" xlink:label="loc_us-gaapAdditionalPaidInCapital_be501e" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStockholdersEquityAbstract_eae148" xlink:to="loc_us-gaapAdditionalPaidInCapital_be501e" order="20" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_RetainedEarningsAccumulatedDeficit" xlink:label="loc_us-gaapRetainedEarningsAccumulatedDeficit_45c984" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStockholdersEquityAbstract_eae148" xlink:to="loc_us-gaapRetainedEarningsAccumulatedDeficit_45c984" order="21" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_StockholdersEquity" xlink:label="loc_us-gaapStockholdersEquity_7a3ee0" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStockholdersEquityAbstract_eae148" xlink:to="loc_us-gaapStockholdersEquity_7a3ee0" order="22" preferredLabel="http://www.xbrl.org/2003/role/totalLabel" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_LiabilitiesAndStockholdersEquity" xlink:label="loc_us-gaapLiabilitiesAndStockholdersEquity_de5c6e" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementOfFinancialPositionAbstract_10a1ef" xlink:to="loc_us-gaapLiabilitiesAndStockholdersEquity_de5c6e" order="23" preferredLabel="http://www.xbrl.org/2003/role/totalLabel" />
  </link:presentationLink>
  <link:presentationLink xlink:type="extended" xlink:role="http://pharmaceuticalresource.com/role/CondensedConsolidatedBalanceSheetParenthetical" xlink:title="110201 - Statement - Condensed Consolidated Balance Sheet (Parenthetical)">
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_StatementOfFinancialPositionAbstract" xlink:label="loc_us-gaapStatementOfFinancialPositionAbstract_1077f0" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_CommonStockParOrStatedValuePerShare" xlink:label="loc_us-gaapCommonStockParOrStatedValuePerShare_319362" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementOfFinancialPositionAbstract_1077f0" xlink:to="loc_us-gaapCommonStockParOrStatedValuePerShare_319362" order="1" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_CommonStockSharesAuthorized" xlink:label="loc_us-gaapCommonStockSharesAuthorized_107e0a" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementOfFinancialPositionAbstract_1077f0" xlink:to="loc_us-gaapCommonStockSharesAuthorized_107e0a" order="2" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_CommonStockSharesIssued" xlink:label="loc_us-gaapCommonStockSharesIssued_78e056" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementOfFinancialPositionAbstract_1077f0" xlink:to="loc_us-gaapCommonStockSharesIssued_78e056" order="3" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_CommonStockSharesOutstanding" xlink:label="loc_us-gaapCommonStockSharesOutstanding_67cd5c" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementOfFinancialPositionAbstract_1077f0" xlink:to="loc_us-gaapCommonStockSharesOutstanding_67cd5c" order="4" />
  </link:presentationLink>
  <link:presentationLink xlink:type="extended" xlink:role="http://pharmaceuticalresource.com/role/CondensedConsolidatedStatementOfOperationsUnaudited" xlink:title="124100 - Statement - Condensed Consolidated Statement of Operations (UNAUDITED)">
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_IncomeStatementAbstract" xlink:label="loc_us-gaapIncomeStatementAbstract_d67ea2" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_Revenues" xlink:label="loc_us-gaapRevenues_c91cc7" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapIncomeStatementAbstract_d67ea2" xlink:to="loc_us-gaapRevenues_c91cc7" order="1" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_CostOfRevenue" xlink:label="loc_us-gaapCostOfRevenue_1cdb23" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapIncomeStatementAbstract_d67ea2" xlink:to="loc_us-gaapCostOfRevenue_1cdb23" order="2" preferredLabel="http://www.xbrl.org/2009/role/negatedLabel" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_GrossProfit" xlink:label="loc_us-gaapGrossProfit_b4400d" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapIncomeStatementAbstract_d67ea2" xlink:to="loc_us-gaapGrossProfit_b4400d" order="3" preferredLabel="http://www.xbrl.org/2003/role/totalLabel" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_OperatingExpensesAbstract" xlink:label="loc_us-gaapOperatingExpensesAbstract_8c1a51" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapIncomeStatementAbstract_d67ea2" xlink:to="loc_us-gaapOperatingExpensesAbstract_8c1a51" order="4" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_GeneralAndAdministrativeExpense" xlink:label="loc_us-gaapGeneralAndAdministrativeExpense_9a3ba5" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapOperatingExpensesAbstract_8c1a51" xlink:to="loc_us-gaapGeneralAndAdministrativeExpense_9a3ba5" order="5" preferredLabel="http://www.xbrl.org/2009/role/negatedLabel" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest" xlink:label="loc_us-gaapIncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest_9be509" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapOperatingExpensesAbstract_8c1a51" xlink:to="loc_us-gaapIncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest_9be509" order="6" preferredLabel="http://www.xbrl.org/2003/role/totalLabel" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_IncomeTaxExpenseBenefit" xlink:label="loc_us-gaapIncomeTaxExpenseBenefit_eeab45" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapOperatingExpensesAbstract_8c1a51" xlink:to="loc_us-gaapIncomeTaxExpenseBenefit_eeab45" order="7" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_NetIncomeLoss" xlink:label="loc_us-gaapNetIncomeLoss_88eadf" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapIncomeStatementAbstract_d67ea2" xlink:to="loc_us-gaapNetIncomeLoss_88eadf" order="8" preferredLabel="http://www.xbrl.org/2003/role/totalLabel" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_EarningsPerShareAbstract" xlink:label="loc_us-gaapEarningsPerShareAbstract_e3df74" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapIncomeStatementAbstract_d67ea2" xlink:to="loc_us-gaapEarningsPerShareAbstract_e3df74" order="9" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_EarningsPerShareDiluted" xlink:label="loc_us-gaapEarningsPerShareDiluted_37dcd4" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapEarningsPerShareAbstract_e3df74" xlink:to="loc_us-gaapEarningsPerShareDiluted_37dcd4" order="10" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding" xlink:label="loc_us-gaapWeightedAverageNumberOfDilutedSharesOutstanding_e5ae91" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapIncomeStatementAbstract_d67ea2" xlink:to="loc_us-gaapWeightedAverageNumberOfDilutedSharesOutstanding_e5ae91" order="11" />
  </link:presentationLink>
  <link:presentationLink xlink:type="extended" xlink:role="http://pharmaceuticalresource.com/role/CondensedConsolidatedCashFlowStatementUnaudited" xlink:title="170000 - Statement - Condensed Consolidated Cash Flow Statement (UNAUDITED)">
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_StatementOfCashFlowsAbstract" xlink:label="loc_us-gaapStatementOfCashFlowsAbstract_2f487b" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_NetCashProvidedByUsedInOperatingActivitiesAbstract" xlink:label="loc_us-gaapNetCashProvidedByUsedInOperatingActivitiesAbstract_60b0d8" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementOfCashFlowsAbstract_2f487b" xlink:to="loc_us-gaapNetCashProvidedByUsedInOperatingActivitiesAbstract_60b0d8" order="1" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_NetIncomeLoss" xlink:label="loc_us-gaapNetIncomeLoss_f369ae" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementOfCashFlowsAbstract_2f487b" xlink:to="loc_us-gaapNetIncomeLoss_f369ae" order="2" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_Depreciation" xlink:label="loc_us-gaapDepreciation_39268d" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementOfCashFlowsAbstract_2f487b" xlink:to="loc_us-gaapDepreciation_39268d" order="3" />
    <link:loc xlink:type="locator" xlink:href="prt-20260630.xsd#prt_DepreciationOfRightOfUseAsset" xlink:label="loc_prtDepreciationOfRightOfUseAsset_48cd92" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementOfCashFlowsAbstract_2f487b" xlink:to="loc_prtDepreciationOfRightOfUseAsset_48cd92" order="4" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_DepreciationAndAmortization" xlink:label="loc_us-gaapDepreciationAndAmortization_95e72b" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementOfCashFlowsAbstract_2f487b" xlink:to="loc_us-gaapDepreciationAndAmortization_95e72b" order="5" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_IncreaseDecreaseInOperatingCapitalAbstract" xlink:label="loc_us-gaapIncreaseDecreaseInOperatingCapitalAbstract_1b5ccb" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementOfCashFlowsAbstract_2f487b" xlink:to="loc_us-gaapIncreaseDecreaseInOperatingCapitalAbstract_1b5ccb" order="6" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_IncreaseDecreaseInInventories" xlink:label="loc_us-gaapIncreaseDecreaseInInventories_ebfb73" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapIncreaseDecreaseInOperatingCapitalAbstract_1b5ccb" xlink:to="loc_us-gaapIncreaseDecreaseInInventories_ebfb73" order="7" preferredLabel="http://www.xbrl.org/2009/role/negatedLabel" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_IncreaseDecreaseInAccruedLiabilities" xlink:label="loc_us-gaapIncreaseDecreaseInAccruedLiabilities_f861b3" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapIncreaseDecreaseInOperatingCapitalAbstract_1b5ccb" xlink:to="loc_us-gaapIncreaseDecreaseInAccruedLiabilities_f861b3" order="8" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_IncreaseDecreaseInAccountsReceivable" xlink:label="loc_us-gaapIncreaseDecreaseInAccountsReceivable_e1e755" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapIncreaseDecreaseInOperatingCapitalAbstract_1b5ccb" xlink:to="loc_us-gaapIncreaseDecreaseInAccountsReceivable_e1e755" order="9" preferredLabel="http://www.xbrl.org/2009/role/negatedLabel" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_IncreaseDecreaseInOperatingLeaseLiability" xlink:label="loc_us-gaapIncreaseDecreaseInOperatingLeaseLiability_6a44a6" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapIncreaseDecreaseInOperatingCapitalAbstract_1b5ccb" xlink:to="loc_us-gaapIncreaseDecreaseInOperatingLeaseLiability_6a44a6" order="10" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_NetCashProvidedByUsedInOperatingActivities" xlink:label="loc_us-gaapNetCashProvidedByUsedInOperatingActivities_83ca5d" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapIncreaseDecreaseInOperatingCapitalAbstract_1b5ccb" xlink:to="loc_us-gaapNetCashProvidedByUsedInOperatingActivities_83ca5d" order="11" preferredLabel="http://www.xbrl.org/2003/role/totalLabel" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_NetCashProvidedByUsedInInvestingActivitiesAbstract" xlink:label="loc_us-gaapNetCashProvidedByUsedInInvestingActivitiesAbstract_ab5fed" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementOfCashFlowsAbstract_2f487b" xlink:to="loc_us-gaapNetCashProvidedByUsedInInvestingActivitiesAbstract_ab5fed" order="12" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_PaymentsToAcquirePropertyPlantAndEquipment" xlink:label="loc_us-gaapPaymentsToAcquirePropertyPlantAndEquipment_1c091c" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapNetCashProvidedByUsedInInvestingActivitiesAbstract_ab5fed" xlink:to="loc_us-gaapPaymentsToAcquirePropertyPlantAndEquipment_1c091c" order="13" />
    <link:loc xlink:type="locator" xlink:href="prt-20260630.xsd#prt_PaymentForAdditionsToRightOfUseAsset" xlink:label="loc_prtPaymentForAdditionsToRightOfUseAsset_58711a" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapNetCashProvidedByUsedInInvestingActivitiesAbstract_ab5fed" xlink:to="loc_prtPaymentForAdditionsToRightOfUseAsset_58711a" order="14" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_PaymentsToAcquireIntangibleAssets" xlink:label="loc_us-gaapPaymentsToAcquireIntangibleAssets_0b6588" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapNetCashProvidedByUsedInInvestingActivitiesAbstract_ab5fed" xlink:to="loc_us-gaapPaymentsToAcquireIntangibleAssets_0b6588" order="15" preferredLabel="http://www.xbrl.org/2009/role/negatedLabel" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_NetCashProvidedByUsedInInvestingActivities" xlink:label="loc_us-gaapNetCashProvidedByUsedInInvestingActivities_a4d557" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapNetCashProvidedByUsedInInvestingActivitiesAbstract_ab5fed" xlink:to="loc_us-gaapNetCashProvidedByUsedInInvestingActivities_a4d557" order="16" preferredLabel="http://www.xbrl.org/2003/role/totalLabel" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract" xlink:label="loc_us-gaapNetCashProvidedByUsedInFinancingActivitiesAbstract_9b5dd0" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementOfCashFlowsAbstract_2f487b" xlink:to="loc_us-gaapNetCashProvidedByUsedInFinancingActivitiesAbstract_9b5dd0" order="17" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_ProceedsFromIssuanceOfCommonStock" xlink:label="loc_us-gaapProceedsFromIssuanceOfCommonStock_4e4013" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapNetCashProvidedByUsedInFinancingActivitiesAbstract_9b5dd0" xlink:to="loc_us-gaapProceedsFromIssuanceOfCommonStock_4e4013" order="18" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_NetCashProvidedByUsedInFinancingActivities" xlink:label="loc_us-gaapNetCashProvidedByUsedInFinancingActivities_ed8b68" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapNetCashProvidedByUsedInFinancingActivitiesAbstract_9b5dd0" xlink:to="loc_us-gaapNetCashProvidedByUsedInFinancingActivities_ed8b68" order="19" preferredLabel="http://www.xbrl.org/2003/role/totalLabel" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_AdditionalCashFlowElementsAbstract" xlink:label="loc_us-gaapAdditionalCashFlowElementsAbstract_9a4dfe" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementOfCashFlowsAbstract_2f487b" xlink:to="loc_us-gaapAdditionalCashFlowElementsAbstract_9a4dfe" order="20" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_RepaymentsOfRelatedPartyDebt" xlink:label="loc_us-gaapRepaymentsOfRelatedPartyDebt_6e3360" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapAdditionalCashFlowElementsAbstract_9a4dfe" xlink:to="loc_us-gaapRepaymentsOfRelatedPartyDebt_6e3360" order="21" preferredLabel="http://www.xbrl.org/2009/role/negatedLabel" />
    <link:loc xlink:type="locator" xlink:href="prt-20260630.xsd#prt_NetCashUsedInRepaymentActivityAmount" xlink:label="loc_prtNetCashUsedInRepaymentActivityAmount_82dee0" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapAdditionalCashFlowElementsAbstract_9a4dfe" xlink:to="loc_prtNetCashUsedInRepaymentActivityAmount_82dee0" order="22" preferredLabel="http://www.xbrl.org/2003/role/totalLabel" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect" xlink:label="loc_us-gaapCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect_455186" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementOfCashFlowsAbstract_2f487b" xlink:to="loc_us-gaapCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect_455186" order="23" preferredLabel="http://www.xbrl.org/2003/role/totalLabel" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents" xlink:label="loc_us-gaapCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents_61d7e5" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementOfCashFlowsAbstract_2f487b" xlink:to="loc_us-gaapCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents_61d7e5" order="24" preferredLabel="http://www.xbrl.org/2003/role/periodStartLabel" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents" xlink:label="loc_us-gaapCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents_f4cc6b" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementOfCashFlowsAbstract_2f487b" xlink:to="loc_us-gaapCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents_f4cc6b" order="25" preferredLabel="http://www.xbrl.org/2003/role/periodEndLabel" />
  </link:presentationLink>
  <link:presentationLink xlink:type="extended" xlink:role="http://pharmaceuticalresource.com/role/CondensedStockholdersEquityUnaudited" xlink:title="170001 - Statement - Condensed Stockholders Equity (UNAUDITED)">
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_StatementOfStockholdersEquityAbstract" xlink:label="loc_us-gaapStatementOfStockholdersEquityAbstract_665bf4" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_StatementTable" xlink:label="loc_us-gaapStatementTable_620534" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementOfStockholdersEquityAbstract_665bf4" xlink:to="loc_us-gaapStatementTable_620534" order="100" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_StatementLineItems" xlink:label="loc_us-gaapStatementLineItems_e6d705" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementTable_620534" xlink:to="loc_us-gaapStatementLineItems_e6d705" order="2000" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_StatementEquityComponentsAxis" xlink:label="loc_us-gaapStatementEquityComponentsAxis_9b4092" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementTable_620534" xlink:to="loc_us-gaapStatementEquityComponentsAxis_9b4092" order="1020" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_EquityComponentDomain" xlink:label="loc_us-gaapEquityComponentDomain_4e1a70" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementEquityComponentsAxis_9b4092" xlink:to="loc_us-gaapEquityComponentDomain_4e1a70" order="1020" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_CommonStockMember" xlink:label="loc_us-gaapCommonStockMember_703675" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapEquityComponentDomain_4e1a70" xlink:to="loc_us-gaapCommonStockMember_703675" order="1021" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_AdditionalPaidInCapitalMember" xlink:label="loc_us-gaapAdditionalPaidInCapitalMember_9f4a69" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapEquityComponentDomain_4e1a70" xlink:to="loc_us-gaapAdditionalPaidInCapitalMember_9f4a69" order="1022" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_RetainedEarningsMember" xlink:label="loc_us-gaapRetainedEarningsMember_6200fc" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapEquityComponentDomain_4e1a70" xlink:to="loc_us-gaapRetainedEarningsMember_6200fc" order="1023" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_SharesIssued" xlink:label="loc_us-gaapSharesIssued_3746c1" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementLineItems_e6d705" xlink:to="loc_us-gaapSharesIssued_3746c1" order="1" preferredLabel="http://www.xbrl.org/2003/role/periodStartLabel" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_StockholdersEquity" xlink:label="loc_us-gaapStockholdersEquity_c9e596" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementLineItems_e6d705" xlink:to="loc_us-gaapStockholdersEquity_c9e596" order="2" preferredLabel="http://www.xbrl.org/2003/role/periodStartLabel" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_StockIssuedDuringPeriodSharesNewIssues" xlink:label="loc_us-gaapStockIssuedDuringPeriodSharesNewIssues_6b70af" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementLineItems_e6d705" xlink:to="loc_us-gaapStockIssuedDuringPeriodSharesNewIssues_6b70af" order="3" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_StockIssuedDuringPeriodValueNewIssues" xlink:label="loc_us-gaapStockIssuedDuringPeriodValueNewIssues_13dab0" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementLineItems_e6d705" xlink:to="loc_us-gaapStockIssuedDuringPeriodValueNewIssues_13dab0" order="4" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_ProfitLoss" xlink:label="loc_us-gaapProfitLoss_89f029" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementLineItems_e6d705" xlink:to="loc_us-gaapProfitLoss_89f029" order="5" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_SharesIssued" xlink:label="loc_us-gaapSharesIssued_62642e" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementLineItems_e6d705" xlink:to="loc_us-gaapSharesIssued_62642e" order="6" preferredLabel="http://www.xbrl.org/2003/role/periodEndLabel" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_StockholdersEquity" xlink:label="loc_us-gaapStockholdersEquity_be15ee" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementLineItems_e6d705" xlink:to="loc_us-gaapStockholdersEquity_be15ee" order="7" preferredLabel="http://www.xbrl.org/2003/role/periodEndLabel" />
  </link:presentationLink>
  <link:presentationLink xlink:type="extended" xlink:role="http://xbrl.sec.gov/ecd/role/InsiderTradingArrangements" xlink:title="995445 - Disclosure - Insider Trading Arrangements">
    <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/ecd/2025/ecd-2025.xsd#ecd_InsiderTradingArrLineItems" xlink:label="loc_ecdInsiderTradingArrLineItems_11ce03" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/ecd/2025/ecd-2025.xsd#ecd_Rule10b51ArrAdoptedFlag" xlink:label="loc_ecdRule10b51ArrAdoptedFlag_a6a625" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ecdInsiderTradingArrLineItems_11ce03" xlink:to="loc_ecdRule10b51ArrAdoptedFlag_a6a625" order="2" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/ecd/2025/ecd-2025.xsd#ecd_Rule10b51ArrTrmntdFlag" xlink:label="loc_ecdRule10b51ArrTrmntdFlag_1e7fe5" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ecdInsiderTradingArrLineItems_11ce03" xlink:to="loc_ecdRule10b51ArrTrmntdFlag_1e7fe5" order="3" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/ecd/2025/ecd-2025.xsd#ecd_NonRule10b51ArrAdoptedFlag" xlink:label="loc_ecdNonRule10b51ArrAdoptedFlag_6c4ea1" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ecdInsiderTradingArrLineItems_11ce03" xlink:to="loc_ecdNonRule10b51ArrAdoptedFlag_6c4ea1" order="4" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/ecd/2025/ecd-2025.xsd#ecd_NonRule10b51ArrTrmntdFlag" xlink:label="loc_ecdNonRule10b51ArrTrmntdFlag_db4774" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ecdInsiderTradingArrLineItems_11ce03" xlink:to="loc_ecdNonRule10b51ArrTrmntdFlag_db4774" order="5" />
  </link:presentationLink>
  <link:presentationLink xlink:type="extended" xlink:role="http://pharmaceuticalresource.com/role/OverviewAndBasisOfPresentation" xlink:title="995446 - Disclosure - Overview and Basis of Presentation">
    <link:loc xlink:type="locator" xlink:href="prt-20260630.xsd#prt_NatureOfBusinessAndBasisOfPresentationAbstract" xlink:label="loc_prtNatureOfBusinessAndBasisOfPresentationAbstract_88ceae" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_BusinessDescriptionAndBasisOfPresentationTextBlock" xlink:label="loc_us-gaapBusinessDescriptionAndBasisOfPresentationTextBlock_871a1b" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_prtNatureOfBusinessAndBasisOfPresentationAbstract_88ceae" xlink:to="loc_us-gaapBusinessDescriptionAndBasisOfPresentationTextBlock_871a1b" order="1" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel" />
  </link:presentationLink>
  <link:presentationLink xlink:type="extended" xlink:role="http://pharmaceuticalresource.com/role/GoingConcern" xlink:title="995447 - Disclosure - Going Concern">
    <link:loc xlink:type="locator" xlink:href="prt-20260630.xsd#prt_GoingConcernAbstract" xlink:label="loc_prtGoingConcernAbstract_f2a0b9" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_SubstantialDoubtAboutGoingConcernTextBlock" xlink:label="loc_us-gaapSubstantialDoubtAboutGoingConcernTextBlock_d7e7d8" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_prtGoingConcernAbstract_f2a0b9" xlink:to="loc_us-gaapSubstantialDoubtAboutGoingConcernTextBlock_d7e7d8" order="1" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel" />
  </link:presentationLink>
  <link:presentationLink xlink:type="extended" xlink:role="http://pharmaceuticalresource.com/role/SummaryOfSignificantPolicies" xlink:title="995448 - Disclosure - Summary of Significant Policies">
    <link:loc xlink:type="locator" xlink:href="prt-20260630.xsd#prt_SummaryOfSignificantPoliciesabstract" xlink:label="loc_prtSummaryOfSignificantPoliciesabstract_07b5ac" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_SignificantAccountingPoliciesTextBlock" xlink:label="loc_us-gaapSignificantAccountingPoliciesTextBlock_6c4772" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_prtSummaryOfSignificantPoliciesabstract_07b5ac" xlink:to="loc_us-gaapSignificantAccountingPoliciesTextBlock_6c4772" order="1" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel" />
  </link:presentationLink>
  <link:presentationLink xlink:type="extended" xlink:role="http://pharmaceuticalresource.com/role/CommonStocks" xlink:title="995449 - Disclosure - Common Stocks">
    <link:loc xlink:type="locator" xlink:href="prt-20260630.xsd#prt_CommonStocksAbstract" xlink:label="loc_prtCommonStocksAbstract_44221f" />
    <link:loc xlink:type="locator" xlink:href="prt-20260630.xsd#prt_CommonStocksDisclosureTextBlock" xlink:label="loc_prtCommonStocksDisclosureTextBlock_e30692" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_prtCommonStocksAbstract_44221f" xlink:to="loc_prtCommonStocksDisclosureTextBlock_e30692" order="1" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel" />
  </link:presentationLink>
  <link:presentationLink xlink:type="extended" xlink:role="http://pharmaceuticalresource.com/role/SegmentReporting" xlink:title="995450 - Disclosure - Segment Reporting">
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_DescriptionOfEffectOnPreviouslyReportedSegmentInformationForChangeInCompositionOfReportableSegments" xlink:label="loc_us-gaapDescriptionOfEffectOnPreviouslyReportedSegmentInformationForChangeInCompositionOfReportableSegments_0a363d" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_SegmentReportingDisclosureTextBlock" xlink:label="loc_us-gaapSegmentReportingDisclosureTextBlock_e0b3f8" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapDescriptionOfEffectOnPreviouslyReportedSegmentInformationForChangeInCompositionOfReportableSegments_0a363d" xlink:to="loc_us-gaapSegmentReportingDisclosureTextBlock_e0b3f8" order="1" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel" />
  </link:presentationLink>
  <link:presentationLink xlink:type="extended" xlink:role="http://pharmaceuticalresource.com/role/IncomeTaxes" xlink:title="995451 - Disclosure - Income Taxes">
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_IncomeTaxDisclosureAbstract" xlink:label="loc_us-gaapIncomeTaxDisclosureAbstract_292203" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_IncomeTaxDisclosureTextBlock" xlink:label="loc_us-gaapIncomeTaxDisclosureTextBlock_7ee4de" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapIncomeTaxDisclosureAbstract_292203" xlink:to="loc_us-gaapIncomeTaxDisclosureTextBlock_7ee4de" order="1" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel" />
  </link:presentationLink>
  <link:presentationLink xlink:type="extended" xlink:role="http://pharmaceuticalresource.com/role/ConcentrationOfCreditRiskAndSignificantCustomers" xlink:title="995452 - Disclosure - Concentration of Credit risk and Significant Customers">
    <link:loc xlink:type="locator" xlink:href="prt-20260630.xsd#prt_ConcentrationOfCreditRiskAbstract" xlink:label="loc_prtConcentrationOfCreditRiskAbstract_62ace8" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_ConcentrationRiskDisclosureTextBlock" xlink:label="loc_us-gaapConcentrationRiskDisclosureTextBlock_a73f47" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_prtConcentrationOfCreditRiskAbstract_62ace8" xlink:to="loc_us-gaapConcentrationRiskDisclosureTextBlock_a73f47" order="1" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel" />
  </link:presentationLink>
  <link:presentationLink xlink:type="extended" xlink:role="http://pharmaceuticalresource.com/role/SubsequentEvents" xlink:title="995453 - Disclosure - Subsequent Events">
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_SubsequentEventsAbstract" xlink:label="loc_us-gaapSubsequentEventsAbstract_56ebb1" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_SubsequentEventsTextBlock" xlink:label="loc_us-gaapSubsequentEventsTextBlock_8f37dc" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapSubsequentEventsAbstract_56ebb1" xlink:to="loc_us-gaapSubsequentEventsTextBlock_8f37dc" order="1" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel" />
  </link:presentationLink>
  <link:presentationLink xlink:type="extended" xlink:role="http://pharmaceuticalresource.com/role/ShareholderEquity" xlink:title="995454 - Disclosure - Shareholder Equity">
    <link:loc xlink:type="locator" xlink:href="prt-20260630.xsd#prt_ShareholderEquityAbstract" xlink:label="loc_prtShareholderEquityAbstract_4a9414" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_StockholdersEquityNoteDisclosureTextBlock" xlink:label="loc_us-gaapStockholdersEquityNoteDisclosureTextBlock_a7084d" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_prtShareholderEquityAbstract_4a9414" xlink:to="loc_us-gaapStockholdersEquityNoteDisclosureTextBlock_a7084d" order="1" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel" />
  </link:presentationLink>
  <link:presentationLink xlink:type="extended" xlink:role="http://pharmaceuticalresource.com/role/SummaryOfSignificantPoliciesPolicies" xlink:title="995455 - Disclosure - Summary of Significant Policies (Policies)">
    <link:loc xlink:type="locator" xlink:href="prt-20260630.xsd#prt_SummaryOfSignificantPoliciesabstract" xlink:label="loc_prtSummaryOfSignificantPoliciesabstract_ef4b7e" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_CashAndCashEquivalentsPolicyTextBlock" xlink:label="loc_us-gaapCashAndCashEquivalentsPolicyTextBlock_7d2cfb" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_prtSummaryOfSignificantPoliciesabstract_ef4b7e" xlink:to="loc_us-gaapCashAndCashEquivalentsPolicyTextBlock_7d2cfb" order="1" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_TradeAndOtherAccountsReceivablePolicy" xlink:label="loc_us-gaapTradeAndOtherAccountsReceivablePolicy_9619fc" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_prtSummaryOfSignificantPoliciesabstract_ef4b7e" xlink:to="loc_us-gaapTradeAndOtherAccountsReceivablePolicy_9619fc" order="2" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_InternalUseSoftwarePolicy" xlink:label="loc_us-gaapInternalUseSoftwarePolicy_2c97ff" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_prtSummaryOfSignificantPoliciesabstract_ef4b7e" xlink:to="loc_us-gaapInternalUseSoftwarePolicy_2c97ff" order="3" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_PropertyPlantAndEquipmentPolicyTextBlock" xlink:label="loc_us-gaapPropertyPlantAndEquipmentPolicyTextBlock_401441" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_prtSummaryOfSignificantPoliciesabstract_ef4b7e" xlink:to="loc_us-gaapPropertyPlantAndEquipmentPolicyTextBlock_401441" order="4" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_IntangibleAssetsFiniteLivedPolicy" xlink:label="loc_us-gaapIntangibleAssetsFiniteLivedPolicy_2a4b33" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_prtSummaryOfSignificantPoliciesabstract_ef4b7e" xlink:to="loc_us-gaapIntangibleAssetsFiniteLivedPolicy_2a4b33" order="5" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_FairValueMeasurementPolicyPolicyTextBlock" xlink:label="loc_us-gaapFairValueMeasurementPolicyPolicyTextBlock_11a54f" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_prtSummaryOfSignificantPoliciesabstract_ef4b7e" xlink:to="loc_us-gaapFairValueMeasurementPolicyPolicyTextBlock_11a54f" order="6" />
    <link:loc xlink:type="locator" xlink:href="prt-20260630.xsd#prt_RelatedPartyBalancesAndTransactionPolicyTextBlock" xlink:label="loc_prtRelatedPartyBalancesAndTransactionPolicyTextBlock_ca7485" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_prtSummaryOfSignificantPoliciesabstract_ef4b7e" xlink:to="loc_prtRelatedPartyBalancesAndTransactionPolicyTextBlock_ca7485" order="7" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_LesseeLeasesPolicyTextBlock" xlink:label="loc_us-gaapLesseeLeasesPolicyTextBlock_88ee56" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_prtSummaryOfSignificantPoliciesabstract_ef4b7e" xlink:to="loc_us-gaapLesseeLeasesPolicyTextBlock_88ee56" order="8" />
    <link:loc xlink:type="locator" xlink:href="prt-20260630.xsd#prt_LeaseLiabilitiesPolicyTextBlock" xlink:label="loc_prtLeaseLiabilitiesPolicyTextBlock_578e68" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_prtSummaryOfSignificantPoliciesabstract_ef4b7e" xlink:to="loc_prtLeaseLiabilitiesPolicyTextBlock_578e68" order="9" />
    <link:loc xlink:type="locator" xlink:href="prt-20260630.xsd#prt_AccruedExpensesPolicyTextBlock" xlink:label="loc_prtAccruedExpensesPolicyTextBlock_79b447" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_prtSummaryOfSignificantPoliciesabstract_ef4b7e" xlink:to="loc_prtAccruedExpensesPolicyTextBlock_79b447" order="10" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_RevenueRecognitionPolicyTextBlock" xlink:label="loc_us-gaapRevenueRecognitionPolicyTextBlock_414735" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_prtSummaryOfSignificantPoliciesabstract_ef4b7e" xlink:to="loc_us-gaapRevenueRecognitionPolicyTextBlock_414735" order="11" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_EarningsPerSharePolicyTextBlock" xlink:label="loc_us-gaapEarningsPerSharePolicyTextBlock_52bdff" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_prtSummaryOfSignificantPoliciesabstract_ef4b7e" xlink:to="loc_us-gaapEarningsPerSharePolicyTextBlock_52bdff" order="12" />
    <link:loc xlink:type="locator" xlink:href="prt-20260630.xsd#prt_DeferredRevenuePolicyTextBlock" xlink:label="loc_prtDeferredRevenuePolicyTextBlock_95e946" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_prtSummaryOfSignificantPoliciesabstract_ef4b7e" xlink:to="loc_prtDeferredRevenuePolicyTextBlock_95e946" order="13" />
    <link:loc xlink:type="locator" xlink:href="prt-20260630.xsd#prt_CostOfRevenuePolicyTextBlock" xlink:label="loc_prtCostOfRevenuePolicyTextBlock_d9aae7" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_prtSummaryOfSignificantPoliciesabstract_ef4b7e" xlink:to="loc_prtCostOfRevenuePolicyTextBlock_d9aae7" order="14" />
    <link:loc xlink:type="locator" xlink:href="prt-20260630.xsd#prt_SalesAndMarketingPolicyTextBlock" xlink:label="loc_prtSalesAndMarketingPolicyTextBlock_7dbb3b" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_prtSummaryOfSignificantPoliciesabstract_ef4b7e" xlink:to="loc_prtSalesAndMarketingPolicyTextBlock_7dbb3b" order="15" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_SellingGeneralAndAdministrativeExpensesPolicyTextBlock" xlink:label="loc_us-gaapSellingGeneralAndAdministrativeExpensesPolicyTextBlock_7b5dfa" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_prtSummaryOfSignificantPoliciesabstract_ef4b7e" xlink:to="loc_us-gaapSellingGeneralAndAdministrativeExpensesPolicyTextBlock_7b5dfa" order="16" />
  </link:presentationLink>
  <link:presentationLink xlink:type="extended" xlink:role="http://pharmaceuticalresource.com/role/SummaryOfSignificantPoliciesTables" xlink:title="995456 - Disclosure - Summary of Significant Policies (Tables)">
    <link:loc xlink:type="locator" xlink:href="prt-20260630.xsd#prt_SummaryOfSignificantPoliciesabstract" xlink:label="loc_prtSummaryOfSignificantPoliciesabstract_2284a6" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_ScheduleOfPublicUtilityPropertyPlantAndEquipmentTextBlock" xlink:label="loc_us-gaapScheduleOfPublicUtilityPropertyPlantAndEquipmentTextBlock_57d628" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_prtSummaryOfSignificantPoliciesabstract_2284a6" xlink:to="loc_us-gaapScheduleOfPublicUtilityPropertyPlantAndEquipmentTextBlock_57d628" order="1" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_ScheduleOfIntangibleAssetsAndGoodwillTableTextBlock" xlink:label="loc_us-gaapScheduleOfIntangibleAssetsAndGoodwillTableTextBlock_9ba530" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_prtSummaryOfSignificantPoliciesabstract_2284a6" xlink:to="loc_us-gaapScheduleOfIntangibleAssetsAndGoodwillTableTextBlock_9ba530" order="2" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_ScheduleOfRelatedPartyTransactionsTableTextBlock" xlink:label="loc_us-gaapScheduleOfRelatedPartyTransactionsTableTextBlock_dba0e7" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_prtSummaryOfSignificantPoliciesabstract_2284a6" xlink:to="loc_us-gaapScheduleOfRelatedPartyTransactionsTableTextBlock_dba0e7" order="3" />
    <link:loc xlink:type="locator" xlink:href="prt-20260630.xsd#prt_OperatingLeasesOfLesseeDisclosuresTextBlock" xlink:label="loc_prtOperatingLeasesOfLesseeDisclosuresTextBlock_241451" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_prtSummaryOfSignificantPoliciesabstract_2284a6" xlink:to="loc_prtOperatingLeasesOfLesseeDisclosuresTextBlock_241451" order="4" />
    <link:loc xlink:type="locator" xlink:href="prt-20260630.xsd#prt_OperatingLeaseRightOfUseAssetTableTextBlock" xlink:label="loc_prtOperatingLeaseRightOfUseAssetTableTextBlock_19733e" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_prtSummaryOfSignificantPoliciesabstract_2284a6" xlink:to="loc_prtOperatingLeaseRightOfUseAssetTableTextBlock_19733e" order="5" />
    <link:loc xlink:type="locator" xlink:href="prt-20260630.xsd#prt_OperatingLeaseLiabilityComponentsTableTextBlock" xlink:label="loc_prtOperatingLeaseLiabilityComponentsTableTextBlock_efcea7" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_prtSummaryOfSignificantPoliciesabstract_2284a6" xlink:to="loc_prtOperatingLeaseLiabilityComponentsTableTextBlock_efcea7" order="6" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_LesseeOperatingLeaseLiabilityMaturityTableTextBlock" xlink:label="loc_us-gaapLesseeOperatingLeaseLiabilityMaturityTableTextBlock_87891f" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_prtSummaryOfSignificantPoliciesabstract_2284a6" xlink:to="loc_us-gaapLesseeOperatingLeaseLiabilityMaturityTableTextBlock_87891f" order="7" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_ScheduleOfAccruedLiabilitiesTableTextBlock" xlink:label="loc_us-gaapScheduleOfAccruedLiabilitiesTableTextBlock_dc011e" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_prtSummaryOfSignificantPoliciesabstract_2284a6" xlink:to="loc_us-gaapScheduleOfAccruedLiabilitiesTableTextBlock_dc011e" order="8" />
    <link:loc xlink:type="locator" xlink:href="prt-20260630.xsd#prt_CostOfRevenueTableTextBlock" xlink:label="loc_prtCostOfRevenueTableTextBlock_6ab82f" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_prtSummaryOfSignificantPoliciesabstract_2284a6" xlink:to="loc_prtCostOfRevenueTableTextBlock_6ab82f" order="9" />
    <link:loc xlink:type="locator" xlink:href="prt-20260630.xsd#prt_GeneralAndAdministrativeExpensesTableTextBlock" xlink:label="loc_prtGeneralAndAdministrativeExpensesTableTextBlock_586bb9" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_prtSummaryOfSignificantPoliciesabstract_2284a6" xlink:to="loc_prtGeneralAndAdministrativeExpensesTableTextBlock_586bb9" order="10" />
  </link:presentationLink>
  <link:presentationLink xlink:type="extended" xlink:role="http://pharmaceuticalresource.com/role/SegmentReportingTables" xlink:title="995457 - Disclosure - Segment Reporting (Tables)">
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_DescriptionOfEffectOnPreviouslyReportedSegmentInformationForChangeInCompositionOfReportableSegments" xlink:label="loc_us-gaapDescriptionOfEffectOnPreviouslyReportedSegmentInformationForChangeInCompositionOfReportableSegments_cc9c2b" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_ScheduleOfSegmentReportingInformationBySegmentTextBlock" xlink:label="loc_us-gaapScheduleOfSegmentReportingInformationBySegmentTextBlock_c85853" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapDescriptionOfEffectOnPreviouslyReportedSegmentInformationForChangeInCompositionOfReportableSegments_cc9c2b" xlink:to="loc_us-gaapScheduleOfSegmentReportingInformationBySegmentTextBlock_c85853" order="1" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_ReconciliationOfOperatingProfitLossFromSegmentsToConsolidatedTextBlock" xlink:label="loc_us-gaapReconciliationOfOperatingProfitLossFromSegmentsToConsolidatedTextBlock_4dc33d" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapDescriptionOfEffectOnPreviouslyReportedSegmentInformationForChangeInCompositionOfReportableSegments_cc9c2b" xlink:to="loc_us-gaapReconciliationOfOperatingProfitLossFromSegmentsToConsolidatedTextBlock_4dc33d" order="2" />
  </link:presentationLink>
  <link:presentationLink xlink:type="extended" xlink:role="http://pharmaceuticalresource.com/role/GoingConcernDetailsNarrative" xlink:title="995458 - Disclosure - Going Concern (Details Narrative)">
    <link:loc xlink:type="locator" xlink:href="prt-20260630.xsd#prt_GoingConcernAbstract" xlink:label="loc_prtGoingConcernAbstract_7bf5cb" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_NetIncomeLoss" xlink:label="loc_us-gaapNetIncomeLoss_d4ef6c" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_prtGoingConcernAbstract_7bf5cb" xlink:to="loc_us-gaapNetIncomeLoss_d4ef6c" order="1" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:loc xlink:type="locator" xlink:href="prt-20260630.xsd#prt_WorkingCapitalDeficit" xlink:label="loc_prtWorkingCapitalDeficit_78f26c" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_prtGoingConcernAbstract_7bf5cb" xlink:to="loc_prtWorkingCapitalDeficit_78f26c" order="2" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_StockholdersEquity" xlink:label="loc_us-gaapStockholdersEquity_83dbdb" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_prtGoingConcernAbstract_7bf5cb" xlink:to="loc_us-gaapStockholdersEquity_83dbdb" order="3" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_CashAndCashEquivalentsAtCarryingValue" xlink:label="loc_us-gaapCashAndCashEquivalentsAtCarryingValue_42f128" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_prtGoingConcernAbstract_7bf5cb" xlink:to="loc_us-gaapCashAndCashEquivalentsAtCarryingValue_42f128" order="4" />
  </link:presentationLink>
  <link:presentationLink xlink:type="extended" xlink:role="http://pharmaceuticalresource.com/role/SummaryOfSignificantPoliciesDetails" xlink:title="995459 - Disclosure - Summary of Significant Policies (Details)">
    <link:loc xlink:type="locator" xlink:href="prt-20260630.xsd#prt_SummaryOfSignificantPoliciesabstract" xlink:label="loc_prtSummaryOfSignificantPoliciesabstract_1a2b2c" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_StatementTable" xlink:label="loc_us-gaapStatementTable_ff6006" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_prtSummaryOfSignificantPoliciesabstract_1a2b2c" xlink:to="loc_us-gaapStatementTable_ff6006" order="100" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_StatementLineItems" xlink:label="loc_us-gaapStatementLineItems_b79d29" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementTable_ff6006" xlink:to="loc_us-gaapStatementLineItems_b79d29" order="2000" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_PropertyPlantAndEquipmentByTypeAxis" xlink:label="loc_us-gaapPropertyPlantAndEquipmentByTypeAxis_f4e7f1" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementTable_ff6006" xlink:to="loc_us-gaapPropertyPlantAndEquipmentByTypeAxis_f4e7f1" order="1020" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_PropertyPlantAndEquipmentTypeDomain" xlink:label="loc_us-gaapPropertyPlantAndEquipmentTypeDomain_9a5009" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapPropertyPlantAndEquipmentByTypeAxis_f4e7f1" xlink:to="loc_us-gaapPropertyPlantAndEquipmentTypeDomain_9a5009" order="1020" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_OfficeEquipmentMember" xlink:label="loc_us-gaapOfficeEquipmentMember_7a8141" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapPropertyPlantAndEquipmentTypeDomain_9a5009" xlink:to="loc_us-gaapOfficeEquipmentMember_7a8141" order="1021" />
    <link:loc xlink:type="locator" xlink:href="prt-20260630.xsd#prt_FurnitureFixtureAndFittingMember" xlink:label="loc_prtFurnitureFixtureAndFittingMember_f85f5d" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapPropertyPlantAndEquipmentTypeDomain_9a5009" xlink:to="loc_prtFurnitureFixtureAndFittingMember_f85f5d" order="1022" />
    <link:loc xlink:type="locator" xlink:href="prt-20260630.xsd#prt_ComputerMember" xlink:label="loc_prtComputerMember_883a60" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapPropertyPlantAndEquipmentTypeDomain_9a5009" xlink:to="loc_prtComputerMember_883a60" order="1023" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_MachineryAndEquipmentMember" xlink:label="loc_us-gaapMachineryAndEquipmentMember_bca0cb" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapPropertyPlantAndEquipmentTypeDomain_9a5009" xlink:to="loc_us-gaapMachineryAndEquipmentMember_bca0cb" order="1024" />
    <link:loc xlink:type="locator" xlink:href="prt-20260630.xsd#prt_IndustrialLeaseholdMember" xlink:label="loc_prtIndustrialLeaseholdMember_0d4920" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapPropertyPlantAndEquipmentTypeDomain_9a5009" xlink:to="loc_prtIndustrialLeaseholdMember_0d4920" order="1025" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_PropertyPlantAndEquipmentGross" xlink:label="loc_us-gaapPropertyPlantAndEquipmentGross_b3a13d" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementLineItems_b79d29" xlink:to="loc_us-gaapPropertyPlantAndEquipmentGross_b3a13d" order="1" preferredLabel="http://www.xbrl.org/2003/role/periodStartLabel" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_PropertyPlantAndEquipmentAdditions" xlink:label="loc_us-gaapPropertyPlantAndEquipmentAdditions_e9ff71" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementLineItems_b79d29" xlink:to="loc_us-gaapPropertyPlantAndEquipmentAdditions_e9ff71" order="2" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_PropertyPlantAndEquipmentDisposals" xlink:label="loc_us-gaapPropertyPlantAndEquipmentDisposals_d2cb1c" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementLineItems_b79d29" xlink:to="loc_us-gaapPropertyPlantAndEquipmentDisposals_d2cb1c" order="3" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_PropertyPlantAndEquipmentGross" xlink:label="loc_us-gaapPropertyPlantAndEquipmentGross_5975e3" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementLineItems_b79d29" xlink:to="loc_us-gaapPropertyPlantAndEquipmentGross_5975e3" order="4" preferredLabel="http://www.xbrl.org/2003/role/periodEndLabel" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment" xlink:label="loc_us-gaapAccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment_5796df" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementLineItems_b79d29" xlink:to="loc_us-gaapAccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment_5796df" order="5" preferredLabel="http://www.xbrl.org/2003/role/periodStartLabel" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipmentPeriodIncreaseDecrease" xlink:label="loc_us-gaapAccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipmentPeriodIncreaseDecrease_7d7b05" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementLineItems_b79d29" xlink:to="loc_us-gaapAccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipmentPeriodIncreaseDecrease_7d7b05" order="6" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_AccumulatedDepreciationDepletionAndAmortizationSaleOfPropertyPlantAndEquipment1" xlink:label="loc_us-gaapAccumulatedDepreciationDepletionAndAmortizationSaleOfPropertyPlantAndEquipment1_063936" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementLineItems_b79d29" xlink:to="loc_us-gaapAccumulatedDepreciationDepletionAndAmortizationSaleOfPropertyPlantAndEquipment1_063936" order="7" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment" xlink:label="loc_us-gaapAccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment_0a1bc6" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementLineItems_b79d29" xlink:to="loc_us-gaapAccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment_0a1bc6" order="8" preferredLabel="http://www.xbrl.org/2003/role/periodEndLabel" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_ImpairedAssetsToBeDisposedOfByMethodOtherThanSaleCarryingValueOfAsset" xlink:label="loc_us-gaapImpairedAssetsToBeDisposedOfByMethodOtherThanSaleCarryingValueOfAsset_64da33" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementLineItems_b79d29" xlink:to="loc_us-gaapImpairedAssetsToBeDisposedOfByMethodOtherThanSaleCarryingValueOfAsset_64da33" order="9" />
  </link:presentationLink>
  <link:presentationLink xlink:type="extended" xlink:role="http://pharmaceuticalresource.com/role/SummaryOfSignificantPoliciesDetails1" xlink:title="995460 - Disclosure - Summary of Significant Policies (Details 1)">
    <link:loc xlink:type="locator" xlink:href="prt-20260630.xsd#prt_SummaryOfSignificantPoliciesabstract" xlink:label="loc_prtSummaryOfSignificantPoliciesabstract_82ee4b" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_StatementTable" xlink:label="loc_us-gaapStatementTable_b42da2" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_prtSummaryOfSignificantPoliciesabstract_82ee4b" xlink:to="loc_us-gaapStatementTable_b42da2" order="100" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_StatementLineItems" xlink:label="loc_us-gaapStatementLineItems_dd3d06" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementTable_b42da2" xlink:to="loc_us-gaapStatementLineItems_dd3d06" order="2000" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_IndefiniteLivedIntangibleAssetsByMajorClassAxis" xlink:label="loc_us-gaapIndefiniteLivedIntangibleAssetsByMajorClassAxis_bab83e" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementTable_b42da2" xlink:to="loc_us-gaapIndefiniteLivedIntangibleAssetsByMajorClassAxis_bab83e" order="1020" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_IndefiniteLivedIntangibleAssetsMajorClassNameDomain" xlink:label="loc_us-gaapIndefiniteLivedIntangibleAssetsMajorClassNameDomain_b7312e" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapIndefiniteLivedIntangibleAssetsByMajorClassAxis_bab83e" xlink:to="loc_us-gaapIndefiniteLivedIntangibleAssetsMajorClassNameDomain_b7312e" order="1020" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis" xlink:label="loc_us-gaapFiniteLivedIntangibleAssetsByMajorClassAxis_76aa10" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementTable_b42da2" xlink:to="loc_us-gaapFiniteLivedIntangibleAssetsByMajorClassAxis_76aa10" order="1040" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_FiniteLivedIntangibleAssetsMajorClassNameDomain" xlink:label="loc_us-gaapFiniteLivedIntangibleAssetsMajorClassNameDomain_293616" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapFiniteLivedIntangibleAssetsByMajorClassAxis_76aa10" xlink:to="loc_us-gaapFiniteLivedIntangibleAssetsMajorClassNameDomain_293616" order="1040" />
    <link:loc xlink:type="locator" xlink:href="prt-20260630.xsd#prt_QualityCertificationsMember" xlink:label="loc_prtQualityCertificationsMember_ef8d8a" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapIndefiniteLivedIntangibleAssetsMajorClassNameDomain_b7312e" xlink:to="loc_prtQualityCertificationsMember_ef8d8a" order="1041" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_TrademarksMember" xlink:label="loc_us-gaapTrademarksMember_519f66" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapIndefiniteLivedIntangibleAssetsMajorClassNameDomain_b7312e" xlink:to="loc_us-gaapTrademarksMember_519f66" order="1042" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_LicensingAgreementsMember" xlink:label="loc_us-gaapLicensingAgreementsMember_d4e93b" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapIndefiniteLivedIntangibleAssetsMajorClassNameDomain_b7312e" xlink:to="loc_us-gaapLicensingAgreementsMember_d4e93b" order="1043" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_PatentsMember" xlink:label="loc_us-gaapPatentsMember_094a39" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapFiniteLivedIntangibleAssetsMajorClassNameDomain_293616" xlink:to="loc_us-gaapPatentsMember_094a39" order="1044" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_FiniteLivedIntangibleAssetsGross" xlink:label="loc_us-gaapFiniteLivedIntangibleAssetsGross_344040" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementLineItems_dd3d06" xlink:to="loc_us-gaapFiniteLivedIntangibleAssetsGross_344040" order="1" preferredLabel="http://www.xbrl.org/2003/role/periodStartLabel" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_FinitelivedIntangibleAssetsAcquired1" xlink:label="loc_us-gaapFinitelivedIntangibleAssetsAcquired1_7ff9fb" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementLineItems_dd3d06" xlink:to="loc_us-gaapFinitelivedIntangibleAssetsAcquired1_7ff9fb" order="2" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_FiniteLivedIntangibleAssetsPeriodIncreaseDecrease" xlink:label="loc_us-gaapFiniteLivedIntangibleAssetsPeriodIncreaseDecrease_568a0d" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementLineItems_dd3d06" xlink:to="loc_us-gaapFiniteLivedIntangibleAssetsPeriodIncreaseDecrease_568a0d" order="3" preferredLabel="http://www.xbrl.org/2009/role/negatedLabel" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_FiniteLivedIntangibleAssetsGross" xlink:label="loc_us-gaapFiniteLivedIntangibleAssetsGross_2c7ddc" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementLineItems_dd3d06" xlink:to="loc_us-gaapFiniteLivedIntangibleAssetsGross_2c7ddc" order="4" preferredLabel="http://www.xbrl.org/2003/role/periodEndLabel" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_FiniteLivedIntangibleAssetsAccumulatedAmortization" xlink:label="loc_us-gaapFiniteLivedIntangibleAssetsAccumulatedAmortization_4bbe3a" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementLineItems_dd3d06" xlink:to="loc_us-gaapFiniteLivedIntangibleAssetsAccumulatedAmortization_4bbe3a" order="5" preferredLabel="http://www.xbrl.org/2003/role/periodStartLabel" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_AmortizationOfIntangibleAssets" xlink:label="loc_us-gaapAmortizationOfIntangibleAssets_5c252e" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementLineItems_dd3d06" xlink:to="loc_us-gaapAmortizationOfIntangibleAssets_5c252e" order="6" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_IndefiniteLivedIntangibleAssetsPeriodIncreaseDecrease" xlink:label="loc_us-gaapIndefiniteLivedIntangibleAssetsPeriodIncreaseDecrease_5fe297" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementLineItems_dd3d06" xlink:to="loc_us-gaapIndefiniteLivedIntangibleAssetsPeriodIncreaseDecrease_5fe297" order="7" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_FiniteLivedIntangibleAssetsAccumulatedAmortization" xlink:label="loc_us-gaapFiniteLivedIntangibleAssetsAccumulatedAmortization_e74f9a" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementLineItems_dd3d06" xlink:to="loc_us-gaapFiniteLivedIntangibleAssetsAccumulatedAmortization_e74f9a" order="8" preferredLabel="http://www.xbrl.org/2003/role/periodEndLabel" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_IntangibleAssetsNetExcludingGoodwill" xlink:label="loc_us-gaapIntangibleAssetsNetExcludingGoodwill_5e357d" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementLineItems_dd3d06" xlink:to="loc_us-gaapIntangibleAssetsNetExcludingGoodwill_5e357d" order="9" />
  </link:presentationLink>
  <link:presentationLink xlink:type="extended" xlink:role="http://pharmaceuticalresource.com/role/SummaryOfSignificantPoliciesDetails2" xlink:title="995461 - Disclosure - Summary of Significant Policies (Details 2)">
    <link:loc xlink:type="locator" xlink:href="prt-20260630.xsd#prt_SummaryOfSignificantPoliciesabstract" xlink:label="loc_prtSummaryOfSignificantPoliciesabstract_b2df31" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_InventoryFirmPurchaseCommitmentLoss" xlink:label="loc_us-gaapInventoryFirmPurchaseCommitmentLoss_378bee" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_prtSummaryOfSignificantPoliciesabstract_b2df31" xlink:to="loc_us-gaapInventoryFirmPurchaseCommitmentLoss_378bee" order="1" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_AccountsReceivableSale" xlink:label="loc_us-gaapAccountsReceivableSale_d09a61" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_prtSummaryOfSignificantPoliciesabstract_b2df31" xlink:to="loc_us-gaapAccountsReceivableSale_d09a61" order="2" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_IncreaseDecreaseInAccountsPayableTrade" xlink:label="loc_us-gaapIncreaseDecreaseInAccountsPayableTrade_48634d" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_prtSummaryOfSignificantPoliciesabstract_b2df31" xlink:to="loc_us-gaapIncreaseDecreaseInAccountsPayableTrade_48634d" order="3" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_FinanceLeaseInterestPaymentOnLiability" xlink:label="loc_us-gaapFinanceLeaseInterestPaymentOnLiability_81b077" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_prtSummaryOfSignificantPoliciesabstract_b2df31" xlink:to="loc_us-gaapFinanceLeaseInterestPaymentOnLiability_81b077" order="4" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_Revenues" xlink:label="loc_us-gaapRevenues_31ddb5" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_prtSummaryOfSignificantPoliciesabstract_b2df31" xlink:to="loc_us-gaapRevenues_31ddb5" order="5" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_OtherCostOfOperatingRevenue" xlink:label="loc_us-gaapOtherCostOfOperatingRevenue_59725b" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_prtSummaryOfSignificantPoliciesabstract_b2df31" xlink:to="loc_us-gaapOtherCostOfOperatingRevenue_59725b" order="6" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_OtherGeneralAndAdministrativeExpense" xlink:label="loc_us-gaapOtherGeneralAndAdministrativeExpense_626d53" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_prtSummaryOfSignificantPoliciesabstract_b2df31" xlink:to="loc_us-gaapOtherGeneralAndAdministrativeExpense_626d53" order="7" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_PaymentsToAcquireOtherPropertyPlantAndEquipment" xlink:label="loc_us-gaapPaymentsToAcquireOtherPropertyPlantAndEquipment_580a1e" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_prtSummaryOfSignificantPoliciesabstract_b2df31" xlink:to="loc_us-gaapPaymentsToAcquireOtherPropertyPlantAndEquipment_580a1e" order="8" />
    <link:loc xlink:type="locator" xlink:href="prt-20260630.xsd#prt_RelatedPartyTransactionOtherRevenuesFromTransactionsWithRelatedPartys" xlink:label="loc_prtRelatedPartyTransactionOtherRevenuesFromTransactionsWithRelatedPartys_d90045" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_prtSummaryOfSignificantPoliciesabstract_b2df31" xlink:to="loc_prtRelatedPartyTransactionOtherRevenuesFromTransactionsWithRelatedPartys_d90045" order="9" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel" />
  </link:presentationLink>
  <link:presentationLink xlink:type="extended" xlink:role="http://pharmaceuticalresource.com/role/SummaryOfSignificantPoliciesDetails3" xlink:title="995462 - Disclosure - Summary of Significant Policies (Details 3)">
    <link:loc xlink:type="locator" xlink:href="prt-20260630.xsd#prt_SummaryOfSignificantPoliciesabstract" xlink:label="loc_prtSummaryOfSignificantPoliciesabstract_fb9695" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_OperatingLeaseRightOfUseAsset" xlink:label="loc_us-gaapOperatingLeaseRightOfUseAsset_c91817" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_prtSummaryOfSignificantPoliciesabstract_fb9695" xlink:to="loc_us-gaapOperatingLeaseRightOfUseAsset_c91817" order="1" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_OperatingLeaseLiability" xlink:label="loc_us-gaapOperatingLeaseLiability_77f925" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_prtSummaryOfSignificantPoliciesabstract_fb9695" xlink:to="loc_us-gaapOperatingLeaseLiability_77f925" order="2" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel" />
  </link:presentationLink>
  <link:presentationLink xlink:type="extended" xlink:role="http://pharmaceuticalresource.com/role/SummaryOfSignificantPoliciesDetails4" xlink:title="995463 - Disclosure - Summary of Significant Policies (Details 4)">
    <link:loc xlink:type="locator" xlink:href="prt-20260630.xsd#prt_SummaryOfSignificantPoliciesabstract" xlink:label="loc_prtSummaryOfSignificantPoliciesabstract_b01c4a" />
    <link:loc xlink:type="locator" xlink:href="prt-20260630.xsd#prt_OperatingActivitiesCashFlowStatement" xlink:label="loc_prtOperatingActivitiesCashFlowStatement_4b85a3" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_prtSummaryOfSignificantPoliciesabstract_b01c4a" xlink:to="loc_prtOperatingActivitiesCashFlowStatement_4b85a3" order="1" />
    <link:loc xlink:type="locator" xlink:href="prt-20260630.xsd#prt_OperatingLeaseWeightedAverageRemainingLeaseTermOne" xlink:label="loc_prtOperatingLeaseWeightedAverageRemainingLeaseTermOne_023d30" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_prtSummaryOfSignificantPoliciesabstract_b01c4a" xlink:to="loc_prtOperatingLeaseWeightedAverageRemainingLeaseTermOne_023d30" order="2" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_OperatingLeaseWeightedAverageDiscountRatePercent" xlink:label="loc_us-gaapOperatingLeaseWeightedAverageDiscountRatePercent_831968" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_prtSummaryOfSignificantPoliciesabstract_b01c4a" xlink:to="loc_us-gaapOperatingLeaseWeightedAverageDiscountRatePercent_831968" order="3" />
  </link:presentationLink>
  <link:presentationLink xlink:type="extended" xlink:role="http://pharmaceuticalresource.com/role/SummaryOfSignificantPoliciesDetails5" xlink:title="995464 - Disclosure - Summary of Significant Policies (Details 5)">
    <link:loc xlink:type="locator" xlink:href="prt-20260630.xsd#prt_SummaryOfSignificantPoliciesabstract" xlink:label="loc_prtSummaryOfSignificantPoliciesabstract_e54f25" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_OperatingLeaseResidualValueOfLeasedAsset" xlink:label="loc_us-gaapOperatingLeaseResidualValueOfLeasedAsset_4782e0" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_prtSummaryOfSignificantPoliciesabstract_e54f25" xlink:to="loc_us-gaapOperatingLeaseResidualValueOfLeasedAsset_4782e0" order="1" preferredLabel="http://www.xbrl.org/2003/role/periodStartLabel" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_OtherDepreciationAndAmortization" xlink:label="loc_us-gaapOtherDepreciationAndAmortization_b5395d" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_prtSummaryOfSignificantPoliciesabstract_e54f25" xlink:to="loc_us-gaapOtherDepreciationAndAmortization_b5395d" order="2" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_OperatingLeaseResidualValueOfLeasedAsset" xlink:label="loc_us-gaapOperatingLeaseResidualValueOfLeasedAsset_d62ffd" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_prtSummaryOfSignificantPoliciesabstract_e54f25" xlink:to="loc_us-gaapOperatingLeaseResidualValueOfLeasedAsset_d62ffd" order="3" preferredLabel="http://www.xbrl.org/2003/role/periodEndLabel" />
  </link:presentationLink>
  <link:presentationLink xlink:type="extended" xlink:role="http://pharmaceuticalresource.com/role/SummaryOfSignificantPoliciesDetails6" xlink:title="995465 - Disclosure - Summary of Significant Policies (Details 6)">
    <link:loc xlink:type="locator" xlink:href="prt-20260630.xsd#prt_SummaryOfSignificantPoliciesabstract" xlink:label="loc_prtSummaryOfSignificantPoliciesabstract_a34f12" />
    <link:loc xlink:type="locator" xlink:href="prt-20260630.xsd#prt_OperatingLeaseLiabilityCurrentAmount" xlink:label="loc_prtOperatingLeaseLiabilityCurrentAmount_c42bff" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_prtSummaryOfSignificantPoliciesabstract_a34f12" xlink:to="loc_prtOperatingLeaseLiabilityCurrentAmount_c42bff" order="1" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_OperatingLeaseLiabilityNoncurrent" xlink:label="loc_us-gaapOperatingLeaseLiabilityNoncurrent_b410fe" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_prtSummaryOfSignificantPoliciesabstract_a34f12" xlink:to="loc_us-gaapOperatingLeaseLiabilityNoncurrent_b410fe" order="2" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_OperatingLeaseLiability" xlink:label="loc_us-gaapOperatingLeaseLiability_a10717" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_prtSummaryOfSignificantPoliciesabstract_a34f12" xlink:to="loc_us-gaapOperatingLeaseLiability_a10717" order="3" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
  </link:presentationLink>
  <link:presentationLink xlink:type="extended" xlink:role="http://pharmaceuticalresource.com/role/SummaryOfSignificantPoliciesDetails7" xlink:title="995466 - Disclosure - Summary of Significant Policies (Details 7)">
    <link:loc xlink:type="locator" xlink:href="prt-20260630.xsd#prt_SummaryOfSignificantPoliciesabstract" xlink:label="loc_prtSummaryOfSignificantPoliciesabstract_2cb8c2" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_LesseeOperatingLeaseLiabilityPaymentsDue" xlink:label="loc_us-gaapLesseeOperatingLeaseLiabilityPaymentsDue_1517c0" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_prtSummaryOfSignificantPoliciesabstract_2cb8c2" xlink:to="loc_us-gaapLesseeOperatingLeaseLiabilityPaymentsDue_1517c0" order="1" />
  </link:presentationLink>
  <link:presentationLink xlink:type="extended" xlink:role="http://pharmaceuticalresource.com/role/SummaryOfSignificantPoliciesDetails8" xlink:title="995467 - Disclosure - Summary of Significant Policies (Details 8)">
    <link:loc xlink:type="locator" xlink:href="prt-20260630.xsd#prt_SummaryOfSignificantPoliciesabstract" xlink:label="loc_prtSummaryOfSignificantPoliciesabstract_e06bac" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_AccruedLiabilitiesCurrentAndNoncurrent" xlink:label="loc_us-gaapAccruedLiabilitiesCurrentAndNoncurrent_98aec5" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_prtSummaryOfSignificantPoliciesabstract_e06bac" xlink:to="loc_us-gaapAccruedLiabilitiesCurrentAndNoncurrent_98aec5" order="1" />
  </link:presentationLink>
  <link:presentationLink xlink:type="extended" xlink:role="http://pharmaceuticalresource.com/role/SummaryOfSignificantPoliciesDetails9" xlink:title="995468 - Disclosure - Summary of Significant Policies (Details 9)">
    <link:loc xlink:type="locator" xlink:href="prt-20260630.xsd#prt_SummaryOfSignificantPoliciesabstract" xlink:label="loc_prtSummaryOfSignificantPoliciesabstract_0cbfc0" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_StatementTable" xlink:label="loc_us-gaapStatementTable_826bae" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_prtSummaryOfSignificantPoliciesabstract_0cbfc0" xlink:to="loc_us-gaapStatementTable_826bae" order="100" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_StatementLineItems" xlink:label="loc_us-gaapStatementLineItems_381701" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementTable_826bae" xlink:to="loc_us-gaapStatementLineItems_381701" order="2000" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/srt/2025/elts/srt-2025.xsd#srt_ProductOrServiceAxis" xlink:label="loc_srtProductOrServiceAxis_21aa8b" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementTable_826bae" xlink:to="loc_srtProductOrServiceAxis_21aa8b" order="1020" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/srt/2025/elts/srt-2025.xsd#srt_ProductsAndServicesDomain" xlink:label="loc_srtProductsAndServicesDomain_a4c2fc" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srtProductOrServiceAxis_21aa8b" xlink:to="loc_srtProductsAndServicesDomain_a4c2fc" order="1020" />
    <link:loc xlink:type="locator" xlink:href="prt-20260630.xsd#prt_MaterialsMember" xlink:label="loc_prtMaterialsMember_7b2af6" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srtProductsAndServicesDomain_a4c2fc" xlink:to="loc_prtMaterialsMember_7b2af6" order="1021" />
    <link:loc xlink:type="locator" xlink:href="prt-20260630.xsd#prt_ConsultationAndSubcontractorsFeesMember" xlink:label="loc_prtConsultationAndSubcontractorsFeesMember_cb501a" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srtProductsAndServicesDomain_a4c2fc" xlink:to="loc_prtConsultationAndSubcontractorsFeesMember_cb501a" order="1022" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_CostOfRevenue" xlink:label="loc_us-gaapCostOfRevenue_908f4b" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementLineItems_381701" xlink:to="loc_us-gaapCostOfRevenue_908f4b" order="1" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel" />
  </link:presentationLink>
  <link:presentationLink xlink:type="extended" xlink:role="http://pharmaceuticalresource.com/role/SummaryOfSignificantPoliciesDetails10" xlink:title="995469 - Disclosure - Summary of Significant Policies (Details 10)">
    <link:loc xlink:type="locator" xlink:href="prt-20260630.xsd#prt_SummaryOfSignificantPoliciesabstract" xlink:label="loc_prtSummaryOfSignificantPoliciesabstract_d34c74" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_MarketingAndAdvertisingExpense" xlink:label="loc_us-gaapMarketingAndAdvertisingExpense_60514d" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_prtSummaryOfSignificantPoliciesabstract_d34c74" xlink:to="loc_us-gaapMarketingAndAdvertisingExpense_60514d" order="1" />
    <link:loc xlink:type="locator" xlink:href="prt-20260630.xsd#prt_AccumulatedDepreciationAmortizationSaleOfPropertyPlantAndEquipment1" xlink:label="loc_prtAccumulatedDepreciationAmortizationSaleOfPropertyPlantAndEquipment1_6253b8" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_prtSummaryOfSignificantPoliciesabstract_d34c74" xlink:to="loc_prtAccumulatedDepreciationAmortizationSaleOfPropertyPlantAndEquipment1_6253b8" order="2" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_DirectCostsOfLeasedAndRentedPropertyOrEquipment" xlink:label="loc_us-gaapDirectCostsOfLeasedAndRentedPropertyOrEquipment_a20e07" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_prtSummaryOfSignificantPoliciesabstract_d34c74" xlink:to="loc_us-gaapDirectCostsOfLeasedAndRentedPropertyOrEquipment_a20e07" order="3" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_OtherGeneralExpense" xlink:label="loc_us-gaapOtherGeneralExpense_aad608" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_prtSummaryOfSignificantPoliciesabstract_d34c74" xlink:to="loc_us-gaapOtherGeneralExpense_aad608" order="4" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_GeneralInsuranceExpense" xlink:label="loc_us-gaapGeneralInsuranceExpense_5e30dd" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_prtSummaryOfSignificantPoliciesabstract_d34c74" xlink:to="loc_us-gaapGeneralInsuranceExpense_5e30dd" order="5" />
    <link:loc xlink:type="locator" xlink:href="prt-20260630.xsd#prt_InternetServicesExpences" xlink:label="loc_prtInternetServicesExpences_783297" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_prtSummaryOfSignificantPoliciesabstract_d34c74" xlink:to="loc_prtInternetServicesExpences_783297" order="6" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_OperatingCostsAndExpenses" xlink:label="loc_us-gaapOperatingCostsAndExpenses_cce3d9" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_prtSummaryOfSignificantPoliciesabstract_d34c74" xlink:to="loc_us-gaapOperatingCostsAndExpenses_cce3d9" order="7" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_ProfessionalFees" xlink:label="loc_us-gaapProfessionalFees_fbb72b" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_prtSummaryOfSignificantPoliciesabstract_d34c74" xlink:to="loc_us-gaapProfessionalFees_fbb72b" order="8" />
    <link:loc xlink:type="locator" xlink:href="prt-20260630.xsd#prt_OtherTelephoneCharges" xlink:label="loc_prtOtherTelephoneCharges_69bb6d" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_prtSummaryOfSignificantPoliciesabstract_d34c74" xlink:to="loc_prtOtherTelephoneCharges_69bb6d" order="9" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_ResultsOfOperationsTransportationCosts" xlink:label="loc_us-gaapResultsOfOperationsTransportationCosts_0cffa6" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_prtSummaryOfSignificantPoliciesabstract_d34c74" xlink:to="loc_us-gaapResultsOfOperationsTransportationCosts_0cffa6" order="10" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_TravelAndEntertainmentExpense" xlink:label="loc_us-gaapTravelAndEntertainmentExpense_04e068" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_prtSummaryOfSignificantPoliciesabstract_d34c74" xlink:to="loc_us-gaapTravelAndEntertainmentExpense_04e068" order="11" />
    <link:loc xlink:type="locator" xlink:href="prt-20260630.xsd#prt_OtherTravelAndEntertainmentExpense" xlink:label="loc_prtOtherTravelAndEntertainmentExpense_600c19" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_prtSummaryOfSignificantPoliciesabstract_d34c74" xlink:to="loc_prtOtherTravelAndEntertainmentExpense_600c19" order="12" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_UtilitiesOperatingExpense" xlink:label="loc_us-gaapUtilitiesOperatingExpense_ea8e2f" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_prtSummaryOfSignificantPoliciesabstract_d34c74" xlink:to="loc_us-gaapUtilitiesOperatingExpense_ea8e2f" order="13" />
    <link:loc xlink:type="locator" xlink:href="prt-20260630.xsd#prt_ProjectFeesExpenses" xlink:label="loc_prtProjectFeesExpenses_7944cf" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_prtSummaryOfSignificantPoliciesabstract_d34c74" xlink:to="loc_prtProjectFeesExpenses_7944cf" order="14" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_InterestExpense" xlink:label="loc_us-gaapInterestExpense_995a7e" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_prtSummaryOfSignificantPoliciesabstract_d34c74" xlink:to="loc_us-gaapInterestExpense_995a7e" order="15" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_LegalFees" xlink:label="loc_us-gaapLegalFees_a67af4" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_prtSummaryOfSignificantPoliciesabstract_d34c74" xlink:to="loc_us-gaapLegalFees_a67af4" order="16" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_SellingGeneralAndAdministrativeExpense" xlink:label="loc_us-gaapSellingGeneralAndAdministrativeExpense_90c4b5" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_prtSummaryOfSignificantPoliciesabstract_d34c74" xlink:to="loc_us-gaapSellingGeneralAndAdministrativeExpense_90c4b5" order="17" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel" />
  </link:presentationLink>
  <link:presentationLink xlink:type="extended" xlink:role="http://pharmaceuticalresource.com/role/SummaryOfSignificantPoliciesDetailsNarrative" xlink:title="995470 - Disclosure - Summary of Significant Policies (Details Narrative)">
    <link:loc xlink:type="locator" xlink:href="prt-20260630.xsd#prt_SummaryOfSignificantPoliciesabstract" xlink:label="loc_prtSummaryOfSignificantPoliciesabstract_5791bb" />
    <link:loc xlink:type="locator" xlink:href="prt-20260630.xsd#prt_DescriptionOfPropertyPlantAndEquipmentFuelUsefulLifeAndAmount" xlink:label="loc_prtDescriptionOfPropertyPlantAndEquipmentFuelUsefulLifeAndAmount_f94516" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_prtSummaryOfSignificantPoliciesabstract_5791bb" xlink:to="loc_prtDescriptionOfPropertyPlantAndEquipmentFuelUsefulLifeAndAmount_f94516" order="1" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_DeferredIncomeRevenueRecognized" xlink:label="loc_us-gaapDeferredIncomeRevenueRecognized_778bb6" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_prtSummaryOfSignificantPoliciesabstract_5791bb" xlink:to="loc_us-gaapDeferredIncomeRevenueRecognized_778bb6" order="2" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_CashEquivalentsAtCarryingValue" xlink:label="loc_us-gaapCashEquivalentsAtCarryingValue_780340" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_prtSummaryOfSignificantPoliciesabstract_5791bb" xlink:to="loc_us-gaapCashEquivalentsAtCarryingValue_780340" order="3" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_NetIncomeLoss" xlink:label="loc_us-gaapNetIncomeLoss_d888c0" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_prtSummaryOfSignificantPoliciesabstract_5791bb" xlink:to="loc_us-gaapNetIncomeLoss_d888c0" order="4" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_WeightedAverageNumberDilutedSharesOutstandingAdjustment" xlink:label="loc_us-gaapWeightedAverageNumberDilutedSharesOutstandingAdjustment_748f16" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_prtSummaryOfSignificantPoliciesabstract_5791bb" xlink:to="loc_us-gaapWeightedAverageNumberDilutedSharesOutstandingAdjustment_748f16" order="5" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_EarningsPerShareDiluted" xlink:label="loc_us-gaapEarningsPerShareDiluted_2e3c83" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_prtSummaryOfSignificantPoliciesabstract_5791bb" xlink:to="loc_us-gaapEarningsPerShareDiluted_2e3c83" order="6" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_MarketingAndAdvertisingExpense" xlink:label="loc_us-gaapMarketingAndAdvertisingExpense_849f60" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_prtSummaryOfSignificantPoliciesabstract_5791bb" xlink:to="loc_us-gaapMarketingAndAdvertisingExpense_849f60" order="7" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel" />
  </link:presentationLink>
  <link:presentationLink xlink:type="extended" xlink:role="http://pharmaceuticalresource.com/role/CommonStocksDetailsNarrative" xlink:title="995471 - Disclosure - Common Stocks (Details Narrative)">
    <link:loc xlink:type="locator" xlink:href="prt-20260630.xsd#prt_CommonStocksAbstract" xlink:label="loc_prtCommonStocksAbstract_d879e2" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_StatementTable" xlink:label="loc_us-gaapStatementTable_9330be" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_prtCommonStocksAbstract_d879e2" xlink:to="loc_us-gaapStatementTable_9330be" order="100" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_StatementLineItems" xlink:label="loc_us-gaapStatementLineItems_c44ade" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementTable_9330be" xlink:to="loc_us-gaapStatementLineItems_c44ade" order="2000" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_StatementClassOfStockAxis" xlink:label="loc_us-gaapStatementClassOfStockAxis_afce72" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementTable_9330be" xlink:to="loc_us-gaapStatementClassOfStockAxis_afce72" order="1020" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_ClassOfStockDomain" xlink:label="loc_us-gaapClassOfStockDomain_4deca7" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementClassOfStockAxis_afce72" xlink:to="loc_us-gaapClassOfStockDomain_4deca7" order="1020" />
    <link:loc xlink:type="locator" xlink:href="prt-20260630.xsd#prt_CommonStocksOneMember" xlink:label="loc_prtCommonStocksOneMember_2d3387" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapClassOfStockDomain_4deca7" xlink:to="loc_prtCommonStocksOneMember_2d3387" order="1021" />
    <link:loc xlink:type="locator" xlink:href="prt-20260630.xsd#prt_CommonStocksMember" xlink:label="loc_prtCommonStocksMember_8da81f" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapClassOfStockDomain_4deca7" xlink:to="loc_prtCommonStocksMember_8da81f" order="1022" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_CommonStockParOrStatedValuePerShare" xlink:label="loc_us-gaapCommonStockParOrStatedValuePerShare_d44a54" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementLineItems_c44ade" xlink:to="loc_us-gaapCommonStockParOrStatedValuePerShare_d44a54" order="1" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_StockIssuedDuringPeriodSharesNewIssues" xlink:label="loc_us-gaapStockIssuedDuringPeriodSharesNewIssues_8a8177" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_prtCommonStocksAbstract_d879e2" xlink:to="loc_us-gaapStockIssuedDuringPeriodSharesNewIssues_8a8177" order="2" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel" />
  </link:presentationLink>
  <link:presentationLink xlink:type="extended" xlink:role="http://pharmaceuticalresource.com/role/SegmentReportingDetails" xlink:title="995472 - Disclosure - Segment Reporting (Details)">
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_DescriptionOfEffectOnPreviouslyReportedSegmentInformationForChangeInCompositionOfReportableSegments" xlink:label="loc_us-gaapDescriptionOfEffectOnPreviouslyReportedSegmentInformationForChangeInCompositionOfReportableSegments_3e8f0a" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_StatementTable" xlink:label="loc_us-gaapStatementTable_2346c3" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapDescriptionOfEffectOnPreviouslyReportedSegmentInformationForChangeInCompositionOfReportableSegments_3e8f0a" xlink:to="loc_us-gaapStatementTable_2346c3" order="100" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_StatementLineItems" xlink:label="loc_us-gaapStatementLineItems_7b8593" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementTable_2346c3" xlink:to="loc_us-gaapStatementLineItems_7b8593" order="2000" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_ConcentrationRiskByBenchmarkAxis" xlink:label="loc_us-gaapConcentrationRiskByBenchmarkAxis_48af18" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementTable_2346c3" xlink:to="loc_us-gaapConcentrationRiskByBenchmarkAxis_48af18" order="1020" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_ConcentrationRiskBenchmarkDomain" xlink:label="loc_us-gaapConcentrationRiskBenchmarkDomain_b04ab3" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapConcentrationRiskByBenchmarkAxis_48af18" xlink:to="loc_us-gaapConcentrationRiskBenchmarkDomain_b04ab3" order="1020" />
    <link:loc xlink:type="locator" xlink:href="prt-20260630.xsd#prt_HoneyStrawManufacturingMember" xlink:label="loc_prtHoneyStrawManufacturingMember_2738b0" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapConcentrationRiskBenchmarkDomain_b04ab3" xlink:to="loc_prtHoneyStrawManufacturingMember_2738b0" order="1021" />
    <link:loc xlink:type="locator" xlink:href="prt-20260630.xsd#prt_PharmaceuticalandDietarySupplementManufacturingMember" xlink:label="loc_prtPharmaceuticalandDietarySupplementManufacturingMember_077251" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapConcentrationRiskBenchmarkDomain_b04ab3" xlink:to="loc_prtPharmaceuticalandDietarySupplementManufacturingMember_077251" order="1022" />
    <link:loc xlink:type="locator" xlink:href="prt-20260630.xsd#prt_BuildingandconstructionServicesMember" xlink:label="loc_prtBuildingandconstructionServicesMember_6c3f00" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapConcentrationRiskBenchmarkDomain_b04ab3" xlink:to="loc_prtBuildingandconstructionServicesMember_6c3f00" order="1023" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_Revenues" xlink:label="loc_us-gaapRevenues_e885c8" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementLineItems_7b8593" xlink:to="loc_us-gaapRevenues_e885c8" order="1" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_CostsAndExpenses" xlink:label="loc_us-gaapCostsAndExpenses_8cf0df" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementLineItems_7b8593" xlink:to="loc_us-gaapCostsAndExpenses_8cf0df" order="2" preferredLabel="http://www.xbrl.org/2009/role/negatedLabel" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_ProfitLoss" xlink:label="loc_us-gaapProfitLoss_9184f9" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementLineItems_7b8593" xlink:to="loc_us-gaapProfitLoss_9184f9" order="3" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel" />
  </link:presentationLink>
  <link:presentationLink xlink:type="extended" xlink:role="http://pharmaceuticalresource.com/role/SegmentReportingDetails1" xlink:title="995473 - Disclosure - Segment Reporting (Details 1)">
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_DescriptionOfEffectOnPreviouslyReportedSegmentInformationForChangeInCompositionOfReportableSegments" xlink:label="loc_us-gaapDescriptionOfEffectOnPreviouslyReportedSegmentInformationForChangeInCompositionOfReportableSegments_c8b43c" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_StatementTable" xlink:label="loc_us-gaapStatementTable_ea6c1f" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapDescriptionOfEffectOnPreviouslyReportedSegmentInformationForChangeInCompositionOfReportableSegments_c8b43c" xlink:to="loc_us-gaapStatementTable_ea6c1f" order="100" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_StatementLineItems" xlink:label="loc_us-gaapStatementLineItems_a928c4" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementTable_ea6c1f" xlink:to="loc_us-gaapStatementLineItems_a928c4" order="2000" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_ConcentrationRiskByBenchmarkAxis" xlink:label="loc_us-gaapConcentrationRiskByBenchmarkAxis_5bd109" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementTable_ea6c1f" xlink:to="loc_us-gaapConcentrationRiskByBenchmarkAxis_5bd109" order="1010" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_ConcentrationRiskBenchmarkDomain" xlink:label="loc_us-gaapConcentrationRiskBenchmarkDomain_56f214" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapConcentrationRiskByBenchmarkAxis_5bd109" xlink:to="loc_us-gaapConcentrationRiskBenchmarkDomain_56f214" order="1010" />
    <link:loc xlink:type="locator" xlink:href="prt-20260630.xsd#prt_HoneyStrawManufacturingMember" xlink:label="loc_prtHoneyStrawManufacturingMember_fc5098" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapConcentrationRiskBenchmarkDomain_56f214" xlink:to="loc_prtHoneyStrawManufacturingMember_fc5098" order="1011" />
    <link:loc xlink:type="locator" xlink:href="prt-20260630.xsd#prt_PharmaceuticalandDietarySupplementManufacturingMember" xlink:label="loc_prtPharmaceuticalandDietarySupplementManufacturingMember_e70d3b" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapConcentrationRiskBenchmarkDomain_56f214" xlink:to="loc_prtPharmaceuticalandDietarySupplementManufacturingMember_e70d3b" order="1012" />
    <link:loc xlink:type="locator" xlink:href="prt-20260630.xsd#prt_BuildingandconstructionServicesMember" xlink:label="loc_prtBuildingandconstructionServicesMember_26175e" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapConcentrationRiskBenchmarkDomain_56f214" xlink:to="loc_prtBuildingandconstructionServicesMember_26175e" order="1013" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_Revenues" xlink:label="loc_us-gaapRevenues_aabfcd" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementLineItems_a928c4" xlink:to="loc_us-gaapRevenues_aabfcd" order="1" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_CostOfRevenue" xlink:label="loc_us-gaapCostOfRevenue_5f30ab" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementLineItems_a928c4" xlink:to="loc_us-gaapCostOfRevenue_5f30ab" order="2" preferredLabel="http://www.xbrl.org/2009/role/negatedLabel" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_GrossProfit" xlink:label="loc_us-gaapGrossProfit_33e6b4" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementLineItems_a928c4" xlink:to="loc_us-gaapGrossProfit_33e6b4" order="3" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_GeneralAndAdministrativeExpense" xlink:label="loc_us-gaapGeneralAndAdministrativeExpense_d1a794" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementLineItems_a928c4" xlink:to="loc_us-gaapGeneralAndAdministrativeExpense_d1a794" order="4" preferredLabel="http://www.xbrl.org/2009/role/negatedLabel" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest" xlink:label="loc_us-gaapIncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest_065abc" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementLineItems_a928c4" xlink:to="loc_us-gaapIncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest_065abc" order="5" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_IncomeTaxExpenseBenefit" xlink:label="loc_us-gaapIncomeTaxExpenseBenefit_1fd16c" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementLineItems_a928c4" xlink:to="loc_us-gaapIncomeTaxExpenseBenefit_1fd16c" order="6" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_NetIncomeLoss" xlink:label="loc_us-gaapNetIncomeLoss_7f88ff" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapDescriptionOfEffectOnPreviouslyReportedSegmentInformationForChangeInCompositionOfReportableSegments_c8b43c" xlink:to="loc_us-gaapNetIncomeLoss_7f88ff" order="7" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
  </link:presentationLink>
  <link:presentationLink xlink:type="extended" xlink:role="http://pharmaceuticalresource.com/role/SegmentReportingDetails2" xlink:title="995474 - Disclosure - Segment Reporting (Details 2)">
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_DescriptionOfEffectOnPreviouslyReportedSegmentInformationForChangeInCompositionOfReportableSegments" xlink:label="loc_us-gaapDescriptionOfEffectOnPreviouslyReportedSegmentInformationForChangeInCompositionOfReportableSegments_877f0e" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_StatementTable" xlink:label="loc_us-gaapStatementTable_08226c" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapDescriptionOfEffectOnPreviouslyReportedSegmentInformationForChangeInCompositionOfReportableSegments_877f0e" xlink:to="loc_us-gaapStatementTable_08226c" order="100" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_StatementLineItems" xlink:label="loc_us-gaapStatementLineItems_53959c" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementTable_08226c" xlink:to="loc_us-gaapStatementLineItems_53959c" order="2000" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_ConcentrationRiskByBenchmarkAxis" xlink:label="loc_us-gaapConcentrationRiskByBenchmarkAxis_91c2cb" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementTable_08226c" xlink:to="loc_us-gaapConcentrationRiskByBenchmarkAxis_91c2cb" order="1010" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_ConcentrationRiskBenchmarkDomain" xlink:label="loc_us-gaapConcentrationRiskBenchmarkDomain_507888" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapConcentrationRiskByBenchmarkAxis_91c2cb" xlink:to="loc_us-gaapConcentrationRiskBenchmarkDomain_507888" order="1010" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_ConcentrationRiskByTypeAxis" xlink:label="loc_us-gaapConcentrationRiskByTypeAxis_f036d9" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementTable_08226c" xlink:to="loc_us-gaapConcentrationRiskByTypeAxis_f036d9" order="1030" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_ConcentrationRiskTypeDomain" xlink:label="loc_us-gaapConcentrationRiskTypeDomain_40799d" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapConcentrationRiskByTypeAxis_f036d9" xlink:to="loc_us-gaapConcentrationRiskTypeDomain_40799d" order="1030" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/srt/2025/elts/srt-2025.xsd#srt_MajorCustomersAxis" xlink:label="loc_srtMajorCustomersAxis_f96fd2" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementTable_08226c" xlink:to="loc_srtMajorCustomersAxis_f96fd2" order="1050" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/srt/2025/elts/srt-2025.xsd#srt_NameOfMajorCustomerDomain" xlink:label="loc_srtNameOfMajorCustomerDomain_f6546e" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srtMajorCustomersAxis_f96fd2" xlink:to="loc_srtNameOfMajorCustomerDomain_f6546e" order="1050" />
    <link:loc xlink:type="locator" xlink:href="prt-20260630.xsd#prt_HoneyStrawManufacturingMember" xlink:label="loc_prtHoneyStrawManufacturingMember_0f6bd4" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapConcentrationRiskBenchmarkDomain_507888" xlink:to="loc_prtHoneyStrawManufacturingMember_0f6bd4" order="1051" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel" />
    <link:loc xlink:type="locator" xlink:href="prt-20260630.xsd#prt_RevenueFromBusinessConcentrationRiskMember" xlink:label="loc_prtRevenueFromBusinessConcentrationRiskMember_c30071" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapConcentrationRiskTypeDomain_40799d" xlink:to="loc_prtRevenueFromBusinessConcentrationRiskMember_c30071" order="1052" />
    <link:loc xlink:type="locator" xlink:href="prt-20260630.xsd#prt_PrimaryCustomerMember" xlink:label="loc_prtPrimaryCustomerMember_07942c" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srtNameOfMajorCustomerDomain_f6546e" xlink:to="loc_prtPrimaryCustomerMember_07942c" order="1053" />
    <link:loc xlink:type="locator" xlink:href="prt-20260630.xsd#prt_PharmaceuticalandDietarySupplementManufacturingMember" xlink:label="loc_prtPharmaceuticalandDietarySupplementManufacturingMember_b25698" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapConcentrationRiskBenchmarkDomain_507888" xlink:to="loc_prtPharmaceuticalandDietarySupplementManufacturingMember_b25698" order="1054" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel" />
    <link:loc xlink:type="locator" xlink:href="prt-20260630.xsd#prt_BuildingandconstructionServicesMember" xlink:label="loc_prtBuildingandconstructionServicesMember_797240" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapConcentrationRiskBenchmarkDomain_507888" xlink:to="loc_prtBuildingandconstructionServicesMember_797240" order="1055" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_ConcentrationRiskPercentage1" xlink:label="loc_us-gaapConcentrationRiskPercentage1_b6ee6b" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementLineItems_53959c" xlink:to="loc_us-gaapConcentrationRiskPercentage1_b6ee6b" order="1" />
  </link:presentationLink>
  <link:presentationLink xlink:type="extended" xlink:role="http://pharmaceuticalresource.com/role/IncomeTaxesDetailsNarrative" xlink:title="995475 - Disclosure - Income Taxes (Details Narrative)">
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_IncomeTaxDisclosureAbstract" xlink:label="loc_us-gaapIncomeTaxDisclosureAbstract_3e79dc" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate" xlink:label="loc_us-gaapEffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate_0964cf" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapIncomeTaxDisclosureAbstract_3e79dc" xlink:to="loc_us-gaapEffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate_0964cf" order="1" />
  </link:presentationLink>
  <link:presentationLink xlink:type="extended" xlink:role="http://pharmaceuticalresource.com/role/ConcentrationOfCreditRiskAndSignificantCustomersDetailsNarrative" xlink:title="995476 - Disclosure - Concentration of Credit risk and Significant Customers (Details Narrative)">
    <link:loc xlink:type="locator" xlink:href="prt-20260630.xsd#prt_ConcentrationOfCreditRiskAbstract" xlink:label="loc_prtConcentrationOfCreditRiskAbstract_f6b842" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_StatementTable" xlink:label="loc_us-gaapStatementTable_e01a98" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_prtConcentrationOfCreditRiskAbstract_f6b842" xlink:to="loc_us-gaapStatementTable_e01a98" order="100" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_StatementLineItems" xlink:label="loc_us-gaapStatementLineItems_275194" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementTable_e01a98" xlink:to="loc_us-gaapStatementLineItems_275194" order="2000" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_ConcentrationRiskByBenchmarkAxis" xlink:label="loc_us-gaapConcentrationRiskByBenchmarkAxis_fb00a8" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementTable_e01a98" xlink:to="loc_us-gaapConcentrationRiskByBenchmarkAxis_fb00a8" order="1010" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_ConcentrationRiskBenchmarkDomain" xlink:label="loc_us-gaapConcentrationRiskBenchmarkDomain_f03642" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapConcentrationRiskByBenchmarkAxis_fb00a8" xlink:to="loc_us-gaapConcentrationRiskBenchmarkDomain_f03642" order="1010" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_ConcentrationRiskByTypeAxis" xlink:label="loc_us-gaapConcentrationRiskByTypeAxis_9839a2" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementTable_e01a98" xlink:to="loc_us-gaapConcentrationRiskByTypeAxis_9839a2" order="1020" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_ConcentrationRiskTypeDomain" xlink:label="loc_us-gaapConcentrationRiskTypeDomain_a7a46a" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapConcentrationRiskByTypeAxis_9839a2" xlink:to="loc_us-gaapConcentrationRiskTypeDomain_a7a46a" order="1020" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/srt/2025/elts/srt-2025.xsd#srt_MajorCustomersAxis" xlink:label="loc_srtMajorCustomersAxis_a1c463" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementTable_e01a98" xlink:to="loc_srtMajorCustomersAxis_a1c463" order="1030" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/srt/2025/elts/srt-2025.xsd#srt_NameOfMajorCustomerDomain" xlink:label="loc_srtNameOfMajorCustomerDomain_6a14f4" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srtMajorCustomersAxis_a1c463" xlink:to="loc_srtNameOfMajorCustomerDomain_6a14f4" order="1030" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_RevenueFromContractWithCustomerMember" xlink:label="loc_us-gaapRevenueFromContractWithCustomerMember_c83205" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapConcentrationRiskBenchmarkDomain_f03642" xlink:to="loc_us-gaapRevenueFromContractWithCustomerMember_c83205" order="1031" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_CustomerConcentrationRiskMember" xlink:label="loc_us-gaapCustomerConcentrationRiskMember_be3625" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapConcentrationRiskTypeDomain_a7a46a" xlink:to="loc_us-gaapCustomerConcentrationRiskMember_be3625" order="1032" />
    <link:loc xlink:type="locator" xlink:href="prt-20260630.xsd#prt_PrimaryCustomerMember" xlink:label="loc_prtPrimaryCustomerMember_d8a9c6" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srtNameOfMajorCustomerDomain_6a14f4" xlink:to="loc_prtPrimaryCustomerMember_d8a9c6" order="1033" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_ConcentrationRiskPercentage1" xlink:label="loc_us-gaapConcentrationRiskPercentage1_eea6d9" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementLineItems_275194" xlink:to="loc_us-gaapConcentrationRiskPercentage1_eea6d9" order="1" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel" />
  </link:presentationLink>
  <link:presentationLink xlink:type="extended" xlink:role="http://pharmaceuticalresource.com/role/ShareholderEquityDetailsNarrative" xlink:title="995477 - Disclosure - Shareholder Equity (Details Narrative)">
    <link:loc xlink:type="locator" xlink:href="prt-20260630.xsd#prt_ShareholderEquityAbstract" xlink:label="loc_prtShareholderEquityAbstract_e4a3a5" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_CommonStockParOrStatedValuePerShare" xlink:label="loc_us-gaapCommonStockParOrStatedValuePerShare_efa90b" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_prtShareholderEquityAbstract_e4a3a5" xlink:to="loc_us-gaapCommonStockParOrStatedValuePerShare_efa90b" order="1" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_CommonStockSharesAuthorized" xlink:label="loc_us-gaapCommonStockSharesAuthorized_433b47" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_prtShareholderEquityAbstract_e4a3a5" xlink:to="loc_us-gaapCommonStockSharesAuthorized_433b47" order="2" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_CommonStockSharesIssued" xlink:label="loc_us-gaapCommonStockSharesIssued_110272" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_prtShareholderEquityAbstract_e4a3a5" xlink:to="loc_us-gaapCommonStockSharesIssued_110272" order="3" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_CommonStockSharesOutstanding" xlink:label="loc_us-gaapCommonStockSharesOutstanding_f34ed1" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_prtShareholderEquityAbstract_e4a3a5" xlink:to="loc_us-gaapCommonStockSharesOutstanding_f34ed1" order="4" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_NetIncomeLoss" xlink:label="loc_us-gaapNetIncomeLoss_e96ae2" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_prtShareholderEquityAbstract_e4a3a5" xlink:to="loc_us-gaapNetIncomeLoss_e96ae2" order="5" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
  </link:presentationLink>
</link:linkbase>
